resume - Health Care Management Department

Transcription

Wharton
MBA Program in
Health Care Management
2015
RESUME
BOOK
Contents
Program Description . . . . . . . . . . . . . . . . . . . . . . 4
Curriculum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Graduates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6-27
Internship Sponsors . . . . . . . . . . . . . . . . . . . . . . 28
Health Care Program Mentors . . . . . . . . . . . 29-32
Administration . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Faculty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34-35
Thank you for your interest in the Wharton MBA Program
in Health Care Management. For further information,
resumes, and appointments, contact:
June Kinney, Associate Director,
MBA Program in Health Care Management
The Wharton School
University of Pennsylvania
3641 Locust Walk
Philadelphia, PA 19104-6218
215.898.6861 | Fax 215.573.2157
email: aleszczc@wharton.upenn.edu
For information on the Wharton Health
Care Management Alumni Association, visit
www.whartonhealthcare.org
For detailed information on the Health Care
Management Department educational programs, visit
http://hcmg.wharton.upenn.edu/
2015
M.B.A. Graduates
The University of Pennsylvania was founded by
Benjamin Franklin in 1740. Although the University
carries the name of the Commonwealth, it is not
a state university but an independent, private,
nonsectarian institution. As one of the country’s
earliest educational institutions, it has consistently
initiated advances in teaching and research and
has steadily generated specialized fields of higher
education. Penn, as the University is commonly
known, was the first American university to form
departments of botany, hygiene and public health,
surgical research, and research medicine. The
University School of Medicine, formed in 1765,
was the first in North America, as was the teaching
hospital founded in 1874. The world’s first
psychological clinic was opened at Penn in 1896.
The Wharton School, in the same spirit of
innovation and excellence, was the world’s first
collegiate school of business and management.
Founded in 1881 with a gift from Joseph Wharton,
the Philadelphia industrialist and philanthropist,
the Wharton School undertook the pioneer steps
in elevating training for business significantly
above its previous level as noncollegiate commercial
education. In 1921, the formation of the Graduate
Program signaled the advancement of business
administration at Wharton to the highest levels
of professional education.
Today, the Wharton School has more than 270
faculty members teaching in both the graduate
and undergraduate divisions and conducting a
continually expanding volume of research. The
1,700 students in the master’s degree program
may choose from among more than 200 courses
and over 18 majors and concentrations, a variety
reflecting the fact that the Wharton education
complements the career goals of the individual.
This brochure is provided to introduce you to
the 2015 Wharton Health Care Management
Program graduates.
We encourage you to consider these individuals
for employment.
3
Program Description
The Graduate Program in Health Care Management
is a full-time two-year MBA curriculum offered
by the Health Care Management Department of
the Wharton School. The program, the principal
educational effort at the Leonard Davis Institute
of Health Economics, is designed to provide
managerial and technical expertise to students
interested in the health care management field.
By combining the skills of the Wharton disciplines
with sensitivity to the needs of health care providers
and recipients, the Wharton MBA health care
graduate can effectively manage the delivery of
health services and products at all levels.
The Program has produced graduates who have
chosen careers in hospitals and other medical
institutions, pharmaceutical, biotechnology and
medical device companies, financial services,
entrepreneurial ventures, consulting firms,
insurance firms, private health industry, and
federal, state, and local government. Many
of these MBA graduates now hold positions
as chief executive officers, directors, and other
key decision makers in health care organizations.
4
The Leonard Davis Institute of Health Economics
(LDI) is an interdisciplinary center for research
and education in the organization, financing,
and delivery of health care. Through LDI, University
of Pennsylvania faculty and staff work together
on issues concerning health policy, health
insurance, managed care, hospitals, corporations,
pharmaceutical companies, and other healthrelated organizations. Established in 1967, the
Institute appropriately bears the name of the late
Leonard Davis, one of the foremost innovators in
private health insurance in the United States. He
was the founder of Colonial Penn Group, Inc., a
company that has pioneered in insurance for older
Americans. Both Mr. Davis and Mrs. Sophie Davis
were generous benefactors to the University of
Pennsylvania, contributing basic support for the
activities of the Leonard Davis Institute.
Curriculum
The Wharton Management Core
All students are required to complete the Wharton Management
Core. The Wharton School’s core curriculum is designed to
increase crossfunctional integration, extend global experience,
strengthen leadership training, and introduce new courses
on key management issues. The core curriculum provides
groundwork in basic management disciplines: economics,
finance, financial and cost accounting, management science,
managing people and organizational design, marketing,
operations management, the governmental and legal
environment of business, statistics, and strategy.
Fixed Core:
• Foundations of Teamwork and Leadership
• Marketing Management
• Quality and Productivity
• Regression Analysis for Business
• Microeconomics for Managers
• Management Communication
Flexible Core:
Accounting
• Financial Accounting or
• Financial and Managerial Accounting or
• Accelerated Financial Accounting
Finance: Corporate Finance
• Corporate Finance or
• Accelerated Corporate Finance or
• Introduction to Corporate Finance
Finance: Macroeconomics
• Macroeconomics and the Global Economic
Environment or
• Introduction to Macroeconomics and the Global
Economic Environment
Legal Studies & Business Ethics
• Responsibility in Global Management or
• Responsibility in Professional Services
Management
• Managing the Established Enterprise or
• Managing the Emerging Enterprise
Marketing
• Dynamic Marketing Strategy or
• Strategic Marketing Simulations
Operations
• Business Analytics or
• Information Technology and Business Transformation or
• Innovation or
• Operations Strategy
• Communications
• Advanced Persuasive Speaking or
• Advanced Persuasion and Data Display or
• Pitching Your Business
Global Immersion Program
The Wharton Global Immersion Program is an optional
half-credit elective course that provides first-year students
with an in-depth exposure to international business
practices and first-hand insights into a foreign culture.
The Health Care Major Courses and Electives
These courses promote an understanding of concepts,
institutions, and issues involved in the organization,
financing, and delivery of health services and products
in the United States. Health care electives are selected
consistent with individual career objectives and interests.
Required
• Health Services System
• Health Care Field Application Project
Electives
• Comparative Health Care Systems
• Financial Management of Health Care Organizations
• Managed Care, Market Structure, and
Health Care Delivery
• Health Business and Policy
• Health Care Marketing
• Healthy Policy
• Legal Aspects of Health Care
• Management and Economics of
Pharmaceutical and Biotechnology Industry
• Medical Devices
• Management of Health Care for the Elderly
• E-Health: Business Models and Impact
• Management of Health Care Services Businesses
• Health Care Entrepreneurship
• Private Sector Role in Global Health
• Health Care Services Delivery:
A Managerial Economic Approach
• Advanced Study Project
The Health Care Summer Internship
The internship is a three-month management experience
which provides the health care major an opportunity
to work with a senior executive in an organization of
particular interest to the student.
MBA Electives
Opportunities are available for the health care major
to pursue a second concentration in fields such as entrepreneurship, marketing, finance, or operations, or to
pursue specialized knowledge in areas such as health care
financing or within specialized segments of the health care
industry including managed care organizations, hospitals,
pharmaceutical and biotechnology companies, medical
device companies, specialty services organizations, and
long term care organizations. Graduate courses are
available throughout the University.
5
Matt R. Adkins
Neil Agarwal
David Allen
matthew.adkins.wg15@wharton.upenn.edu
Brown University, Providence, RI
B.A., Economics / Engineering, 2009
neil.agarwal.wg15@wharton.upenn.edu
University of Maryland, College Park, MD
B.S., Biochemistry, B.S., Mathematics, 2008
Harvard Kennedy School of Government,
Cambridge, MA
M.P.A. Candidate, 2016
david.allen.wg15@wharton.upenn.edu
University of Michigan, Ross School of Business,
Ann Arbor, MI
B.B.A., High Distinction,
Finance and Accounting, 2006
A commercial marketing opportunity
in the biopharmaceutical industry.
An opportunity to use my strategic and
operational expertise to improve value
in health care delivery.
An opportunity to build successful
health care businesses through an
operational or strategic role.
Deloitte Consulting, New York, NY
Summer Associate, Summer 2014
Advised a major foundation in setting
organization-wide strategy for $300M in
health-related funding and investment.
Synthesized primary and secondary
research into strategy white paper to
be used by other large foundations.
Medtronic, Northridge, CA
Marketing Intern, Summer 2014
Designed and initiated a plan to evaluate
and address cost-driven attrition in
the United States for the Diabetes
Business Unit. Developed a consumables
marketing toolkit that was showcased
at an industry conference in August
2014. Created the business case recommendation for launch of a new infusion
set in early 2015.
Pfizer, New York, NY
Marketing Summer Associate, Summer 2014
Led the development of a full,
multi-channel, physician marketing
campaign to announce the potential
US approval of Palbociclib, one of
Pfizer’s most highly anticipated new
drug launches. Presented recommended content strategy to Business
Unit Review Committee to gain alignment on strategy from a regulatory
perspective. Worked with a creative
advertising agency to drive the execution of individual tactics and presented
proposed campaign directly to the
President of North America Oncology.
Simon-Kucher & Partners, Boston, MA
Senior Consultant, 2012-2013
Consultant, 2009-2011
Pricing and marketing consultant for
clients in the pharmaceutical, biotechnology, and medical device industries.
Led project teams of 2-9 consultants
on engagements providing clients with
data-driven strategic recommendations
on topics such as launch pricing, payer
contracting, forecasting, customer
segmentation, messaging strategy,
distribution strategy, and patient
assistance programs. Leveraged
quantitative analysis techniques
including multivariate regression,
cluster analysis, and conjoint analysis
to drive strategic recommendations.
Presented reports and key recommendations to client teams, including senior
management and C-level executives.
6
Mount Sinai Hospital, New York, NY
Summer Administrative Resident,
Summer 2014
Recommended staff allocation modifications that increased OR utilization by
30%. Pinpointed margin contribution
from surgeries using financial and
medical data. Analyzed ER care
processes to reduce wait times and
increase revenue.
Catapult Consultants, Arlington, VA
Health Care Analyst, 2011-2013
Worked with Medicare & Medicaid on
multiple engagements targeting care
quality in hospitals and nursing homes.
Developed data analysis tools; supported
IT system design; created client trainings.
Only analyst invited to aid senior management in new business development.
U.S. Peace Corps, Bondo, Kenya
Public Health Advisor, 2009-2011
Advised 4 rural hospitals on operational
improvements and recommended
changes to Health Ministry’s $1.2M
district budget. Created health
education initiative reaching 2,500
students.
Soros Fund Management, New York, NY
Private Equity Associate, 2010-2013
Member of the private equity group
at Soros Fund Management, the private
family office of the Soros family. As
part of a 16-person team managing a
$3.5B portfolio, primary responsibilities
were to evaluate new investment
opportunities and to manage portfolio
companies in a variety of industries
including telecommunications, wasteto-energy and healthcare.
G.F. Capital Management and Advisors,
New York, NY
$250M private equity fund focused
on media, entertainment, and
branded consumer products. Evaluated
and executed potential opportunities
as the sole associate resource in the
organization with responsibilities
including: developing financial models,
leading due diligence sessions,
coordinating third-party advisors, and
preparing investment memorandums.
Joshua Atwood
Brian P. Belsky
Jonathan P. Brallier
joshua.atwood.wg15@wharton.upenn.edu
Wesleyan University
B.A., Economics and French Studies, 2008
Harvard Kennedy School of Government
brian.belsky.wg15@wharton.upenn.edu
Yale University, New Haven, CT
B.A., Political Science, 2007
jonathan.brallier.wg15@wharton.upenn.edu
Franklin & Marshall College, Lancaster, PA
B.A., Cum Laude, Finance / Accounting, 2007
companies in healthcare through
strategy, business development,
or direct investing.
The opportunity to build successful
businesses through health care focused
private equity investing.
An opportunity to develop and execute
innovative strategies to improve health
care ecosystems.
Health Enterprise Partners, New York, NY
Evaluated more than two dozen
investment opportunities in healthcare
services and IT sectors for firm’s $150M
second fund. Transaction experience
includes preferred equity investment
in InDemand Interpreting, a provider
of video remote interpretation (VRI)
services to the health care provider
market. Worked extensively with
multiple portfolio companies to amend
cash management strategy and forecast
revenue bridge projections.
Booz & Company (nka Strategy&),
New York, NY
MBA Associate, Health Strategy Group,
Summer 2014
Developed product and go-to-market
strategy for the launch of a $5B
consumer-directed business at a major
health insurer. Determined company
and product positioning through
analysis of consumer data, competitive
offerings, and market trends. Designed
an interactive financial operating
model for the future-state business.
Albright Stonebridge Group,
Washington, DC
External Adviser, 2014
Advised multinationals on how best to
navigate complexities of investments
and operations in emerging markets
through commercial diplomacy and
management consulting. Focused
on client service and business development for finance and health care
sectors.
McKinsey & Company, Boston, MA
Engagement Manager 2013
Senior Associate 2012
Business Analyst 2010-2012
Research Analyst 2008-2010
Led large consultant and client teams
across over a dozen projects for leading life sciences, financial services, and
private equity firms. Worked closely
and built relationships with senior
client management across industries,
geographies, and cultures. Designed
and managed complex projects,
creating client deliverables, conducting qualitative and quantitative
analysis, and coaching consultants
and client executives.
World Economic Forum,
Geneva, Switzerland
Project Manager 2012
Developed strategies and policy recommendations for Ministers of Health,
Ministers of Finance, and industry
leaders on health system delivery and
financing. Facilitated CEO and Minister
level discussions at the World
Economic Forum Annual Meeting
at Davos 2012 as well as 10 other
half-day workshops.
Self Health Network, San Francisco, CA
Chief Strategy Officer, 2013
Self Health Network is a readmission
avoidance-focused health care technology company. Responsibilities included
leading successful fundraising effort,
cultivating sales pipeline, developing
new product and preparing eightquarter corporate strategic plan.
Bank of America Merrill Lynch,
New York, NY
Associate, Health Care Investment Banking,
2010-2013
Provided financial, M&A and strategic
advisory services to health care provider
and managed care companies resulting
in more than $1.8B in completed
transactions in 3 years.
Merrill Lynch & Co., New York, NY
Analyst, Tax-Exempt Capital Markets,
2007-2009
Originated and traded credit products
for a Merrill Lynch proprietary fixed
income trading desk as well as thirdparty clients.
Falcon Capital Partners, Philadelphia, PA
Senior Associate, 2009-2013
Managed merger and acquisition,
strategic advisory, and growth financing
assignments in the health care and
information technology industries.
Led investment analyses related to
platform company investments on
behalf of private equity clients, including
Warburg Pincus and Parthenon Capital.
Directly managed client relationships
during several sell-side transactions,
including advising clients on personal
long-term goals and negotiating deal
terms with clients and investors.
Morgan Joseph, Nashville, TN
Analyst, 2007-2009
Participated in the origination, analysis,
and execution of merger and acquisition,
fairness opinion, and general advisory
assignments for clients in various
industries, representing over $1B
in value.
7
Colin W. Brown
Alexandra C. Burtoft
Elif Çar
colin.brown.wg15@wharton.upenn.edu
The University of Chicago, Chicago, IL
B.A., Honors, Philosophy, 2007
Harvard Kennedy School, Cambridge, MA
alexandra.burtoft.wg15@wharton.upenn.edu
Lehigh University, Bethlehem, PA
B.S., High Honors, Bioengineering, 2008
elif.car.wg15@wharton.upenn.edu
Bogazici University, Istanbul, Turkey
B.A., High Honors, Management, 2008
An opportunity to work at the intersection
of healthcare and technology to
improve patient outcomes.
A promotional or strategic marketing
opportunity focused on oncology/
hematology or rare disease within
the biopharmaceutical industry.
An opportunity in consulting with
exposure to the healthcare sector.
Infosys Limited, Pune, India
Intern, Infosys Public Services, Summer 2014
Developed market-entry strategies to
support Infosys’s expansion into the US
healthcare and government sectors.
Worked across sales, marketing, and
product development divisions to
modify existing IT solutions for US
market needs.
Clinton Health Access Initiative
Nairobi, Kenya & Kingston, Jamaica
Associate, Drug Access Team, 2011-2013
Analyst, Jamaica Country Team, 2010-2011
Advised government officials in the
Caribbean and Sub-Saharan Africa
on opportunities to reduce HIV treatment costs and increase quality of care.
Managed $3M grant covering programs
and staff in Kenya, Uganda, Ethiopia,
Tanzania, Nigeria, and Liberia.
Collaborated with procurement
agencies and regulatory authorities
to accelerate the introduction of novel,
life-saving commodities and mitigate
impending stockouts of HIV drugs.
Accretive Health, Chicago, IL
Lead, Measurement Team, 2008-2010
Created complex financial models
to quantify the value of Accretive’s
revenue cycle initiatives. Improved
accuracy of measurements allowed
the company to invoice and collect
on over $10M in outstanding revenue.
8
Celgene Corporation, Summit, NJ
Hematology Marketing Intern. Summer 2014
Evaluated and provided recommendations for potential commercial partnerships with companies filing NDAs for
a drug to be used in combination with
Revlimid. Spearheaded an evaluation
of the current strategy for marketing
to hematology/oncology NPs/PAs and
recommended specific tactics, as well
as increased spend/attention to this
group. Used my commercial regulatory
expertise to lead the creation, review,
and ad agency collaboration for both
consumer- and physician-focused
promotional tactics.
Genentech Inc., South San Francisco, CA
Associate Program Director, 2008-2014
Worked for five years full-time and
for one year on a contract basis as the
promotional review committee (PRC)
lead for multiple brands, including
Boniva, Herceptin, Perjeta, Rituxan
for RA, and Tarceva. Led the product
launch for Perjeta and served as the
main commercial regulatory expert
for cross-functional teams, including
PR, brand marketing, managed care,
access solutions, medical affairs,
corporate communication, commercial
training, etc. Pioneered the “Creating
Perspective” training program to teach
sales representatives about the PRC
process and evolution of brand messaging. The program was nominated
for a RethinkD Award for out-of-the
box thinking for the betterment of
the company.
Alyuta, Istanbul, Turkey
Customer Development Manager, 2012-2013
Led a 4-person team to develop a
cutting-edge marketing analytics tool
for Turkey’s largest hospital chain and
e-commerce companies. Analyzed client
data and made recommendations
based on customer lifecycle analytics,
next-product-to-buy, and customer
lifetime value models.
Pfizer, Istanbul, Turkey
Product Manager, 2009-2012
Project Manager 2008-2009
Responsible for developing and
executing cardiovascular products’
business plans, including the cholesterollowering drug Lipitor. Developed
launch plans for two different products
(Eliquis, Sevikar) including regulatory,
reimbursement, pricing, and marketing strategies by working closely with
cross-functional partners. Planned and
coordinated co-promotion business
models with Bristol-Myers Squibb and
Daiichi Sankyo and led regular executive
meetings with country managers of
both companies to ensure high level
alignment. Developed Turkey’s first
telemedicine project empowering
physicians to track patients’ records
remotely. Devised sales transformation
program for Norvasc (Turkey’s best
selling anti-hypertensive), which
resulted in 20% unit growth and $22M
sales. Identified growth potential in
diabetic patients for Lipitor by consolidating market data with customer
insights and led diabetes projects
resulting in increased treatment rates
of diabetics.
Daisy J. Carrillo
Alli Chandra
Dustin W.M. Chang
daisy.carrillo.wg15@wharton.upenn.edu
University of California, Berkeley, CA
B.S., Industrial Engineering & Operations
Research, 2009
alli.chandra.wg15@wharton.upenn.edu
Harvard University, Cambridge, MA
A.B., Cum Laude, Government, 2010
dustin.chang.wg15@wharton.upenn.edu
Johns Hopkins University, Baltimore, MD
B.A., Economics and Psychology, 2008
An opportunity to apply my business
and technical skill set to strategic and
operational roles focused on leveraging
technology to lower costs, improve
quality and increase access to care.
An operational, financial, or strategic
transformation role with provider
organizations transitioning to
value-based care.
An opportunity in private equity with
exposure to the healthcare industry.
Google, Mountain View, CA
gTech MBA Intern, Summer 2014
Developed a model to conduct a
global data analysis of Google’s technology support team, providing the
VP of Sales with strategic insights and
recommendations related to product
adoption, growth trends, and support
capability gaps. Analyzed data to
identify key drivers of unmet service
metrics, implementing 4 initiatives
that led to a 53% improvement in
total resolution time.
Deloitte Consulting, Los Angeles, CA
Primarily served health insurance
clients across multiple projects in
technology strategy from operations
and process improvement to enterprise-wide system migrations for the
Health Insurance Exchanges. Delivered
a deployment strategy for a newly
acquired health care benefit management application, analyzing risks and
benefits of 4 potential deployment
options. Additionally, conducted a
fit-gap analysis of the client’s customer
service team to determine the
operational impacts of using a new
application. Identified technical
infrastructure needs, process redesign
opportunities and training requirements.
McKinsey & Company, Washington, D.C.
Business Technology Associate, Summer 2014
In first study, conducted market scan
and fit-gap-analysis for claims product
solutions for $1B government project
that client is pursuing. In second study,
developed framework and identified
target companies for $150M HIT
purchasing strategy for payer client.
Center for Medicare & Medicaid
Innovation, Washington D.C.
Special Assistant to the Director, 2012-2013
Launched five payment programs
worth $1.5B under aggressive
administration deadlines by negotiating
technical and press details with senior
leadership in HHS and the White House.
Center for Medicare & Medicaid
Innovation, Washington D.C.
Pioneer Accountable Care
Organization (ACO) Program Officer,
2011-2012
Received Administrator’s Special
Citation Award for exceptional work as
operational lead and program officer
on Pioneer model. Served as sole
Medicare representative to 10 major
health systems. Co-led online peer
learning networks on data analytics,
risk stratification, and predictive
modeling. Crafted alignment algorithm,
beneficiary overlap, attestation, audit,
program monitoring, and reinsurance
policies. Negotiated terms of ACO
contracts with nine health systems
for combined worth of approximately
$10B.
Citadel Investment Group, New York, NY
Global Equities Summer Associate,
Summer 2014
Initiated coverage or made recommendations on five long/short positions.
Developed detailed financial models
to analyze potential investment
opportunities. Conducted fundamental
analysis through primary research;
led discussions with executive management teams.
Galen Partners, Stamford, CT
Associate, 2011-2013
Healthcare private equity firm with
approximately $1B AUM. Assessed
and analyzed investment opportunities
across a range of transaction types,
including growth equity, leveraged
buyout, and private investment in
public equity; proactively sourced
and screened investment opportunities.
Successfully completed five new or
follow-on investments and one portfolio
company sale. Advised portfolio
company management teams on
strategic planning and business
development.
Stifel Nicolaus Weisel, New York, NY /
Baltimore, MD
Healthcare Investment Banking Analyst,
2008-2011
Ranked in the top quartile of analyst
class. Analyzed companies using
comparable company, precedent
transaction, leveraged buyout,
and discounted cash flow analyses.
Supported senior bankers in the
procurement and execution of three
M&A transactions, eight financings
that raised in excess of $1B in equity
and debt capital and one valuation
assignment.
9
Kelly C. Cheng
Cyndi U. Chung
Katherine A.A. Clark
kelly.cheng.wg15@wharton.upenn.edu
Stanford University, Stanford, CA
B.S., Management Science and Engineering, 2009
cyndi.chung.wg15@wharton.upenn.edu
University of Pennsylvania, Philadelphia, PA
B.A., Summa Cum Laude, Phi Beta Kappa,
Biochemistry, English, 2010
M.S., Chemistry, 2010
Perelman School of Medicine at the University
of Pennsylvania, Philadelphia, PA
M.D. Candidate, 2015
katherine.clark.wg15@wharton.upenn.edu
Haverford College, Haverford, PA
B.S., Honors, Chemistry, B.S., Mathematics, 2009
M.D. Candidate 2015
An entrepreneurial opportunity to
address healthcare challenges via
technology innovations.
The integration of my science and
business backgrounds to make health
care more accessible and affordable
for patients.
An opportunity to apply my clinical,
business, and research experiences
to a strategic role in medical device
innovation.
McKinsey & Co., Palo Alto, CA
Summer Associate 2014
Managed the transformation of clinical
trial operations for a global pharmaceutical company. Oversaw several
workstreams that planned and
monitored outsourcing to a contract
research organization.
Becton Dickinson, Franklin Lakes, NJ
Strategic Innovation Intern,
Medical-Surgical Systems, Summer 2014 Developed a business opportunity
strategy in medical oncology to identify
unmet clinical needs and managed a
direct report with full-time dedication
to my project.
Perelman School of Medicine,
Philadelphia, PA
Graduate Student Researcher, 2010-2014
Conducted analyses on risk factors
for and outcomes after mandibular
distraction osteogenesis, autologous
breast reconstruction, and hernia
repair, among other procedures.
Children’s Hospital of Philadelphia,
Philadelphia, PA
Medical Student Researcher, Cardiology,
2012-2013
Studied implanted medical devices
modified to inhibit pro-inflammatory
events. Selected for a presentation at
the Scientific Sessions of the American
Heart Association. Published manuscript
in Biomaterials.
Augmedix, San Francisco, CA
MBA Intern, Summer 2014
Developed new platform strategy by
engaging strategic hardware, software,
content, and services partners. Initiated
account development in Philadelphia
metro region by pitching to 20+ health
system CEOs, CIOs, CMIOs, etc. Designed
and implemented hiring processes for
20+ engineering, operations, sales,
and legal roles, doubling size of SF HQ.
Practice Fusion, San Francisco, CA
Business Development Intern, Summer 2013
Sized revenue opportunity for new
data analytics business line at $15M
in near-term business, projected to
grow to $200M+. Designed and tested
analytics prototypes with 35+ external
health IT, life sciences, and health
provider executives.
Deloitte Consulting, San Francisco, CA
Consultant 2011-2013
Business Analyst 2009-2011
Strategy consultant for clients in
provider, plan, life sciences, telematics,
software, and consumer products
industries. Assessed joint venture
for integrated delivery network to
develop artificial intelligence product
with $107B global technology leader.
Managed partnership development
with $1.4B voice recognition company.
Modeled post-Health Reform market
changes to determine future areas of
growth for $8B US health plan. Used
deliverables to co-develop a Health
Reform Market Offering.
10
Hospital of the University of
Pennsylvania, Philadelphia, PA
Medical Student Researcher, Critical Care,
2012-2013
Conducted interviews and synthesized
clinician surveys of a clinical decision
support tool for sepsis. Refined system
to result in a more sensitive alert.
Selected for an oral presentation
at the Mid-Atlantic Healthcare
Bioinformatics Symposium.
Medical Student Researcher, Interventional
Radiology, 2010
Conducted clinical research on
Hereditary Hemorrhagic Telangiectasia
and central venous access devices.
Selected for two presentations at
European IR Society Conference.
Published manuscript in the American
Journal of Cardiology.
Michael J. Cromwell, IV
Nicholas Y. Crowne
Jennifer A. Dikan
michael.cromwell.wg15@wharton.upenn.edu
University of Michigan, Ann Arbor, MI
B.A./B.B.A, with High Distinction,
Latin and Finance, 2008
nicholas.crowne.wg15@wharton.upenn.edu
A.B., Cum Laude, History, 2008
jennifer.dikan.wg15@wharton.upenn.edu Tufts University, Medford, MA B.S., Biomedical Engineering, 2008
Brown University, Providence, RI
M.S., Engineering, 2009
An opportunity to build leading
healthcare businesses through
investment or management.
An opportunity to identify, build, and
transform market-leading companies.
An opportunity to apply my crossdisciplinary background in engineering
and business in a strategic role focused
on developing innovative care models
and disruptive innovations.
Castlight Health, San Francisco, CA
Strategy Intern, Summer 2014
Analyzed 17 adjacent categories to
inform buy/build/partner decisionmaking for newly public healthcare
technology company. Performed
research on third-party administrator
industry to identify disruptive growth
opportunities, and presented findings
directly to CFO. Developed mergers
and acquisitions template to serve
as valuation screening tool.
Ascension Health Care Network,
New York, NY
Director of Financial Planning and Analysis,
2012-2013
Directed due diligence processes for
prospective hospital acquisitions with
Oak Hill professionals, Ascension Health
subject matter experts, and outside
consultants. Created multi-hospital
leveraged buy-out model to evaluate
hospital consolidation opportunity
with combined revenues of $1B+.
Oak Hill Capital Management,
New York, NY
Performed due diligence, created
financial models and assisted portfolio
company managers for private equity
firm with $3.8B in latest fund.
Executed transactions in home health
(AccentCare), radiation oncology
(Vantage Oncology), and hospital
(Ascension Health Care Network)
sectors.
Barclays Capital / Lehman Brothers,
New York, NY
Healthcare M&A Analyst, 2008-2010
Executed financial models to assess
M&A transactions and capital structure
alternatives.
Mount Kellett Capital Management,
New York, NY
Sourced, diligenced, and presented
public and private equity and credit
opportunities across healthcare, TMT,
business services, and financial institutions. Led research process, including
analysis of unit economics, structural
growth/decline, and investment
catalysts to formulate investment
theses and assess risk/reward.
GTCR, Chicago, IL
Originated and led $2B of private
equity transactions in healthcare
sector across 3 platforms, including
top-performing investment in Fund IX
(Actient Pharmaceuticals), GTCR’s first
life sciences investment (Cord Blood
Registry), and largest healthcare equity investment (Sterigenics). Identified
attractive segments within healthcare
sector, analyzed market attributes,
constructed detailed financial models,
orchestrated due diligence efforts,
and participated in board meetings.
Executed five proprietary acquisitions
in 24 months to build Actient
Pharmaceuticals from management
start-up to successful sale ($645M).
Partnered with management team
to acquire Cord Blood Registry and
worked alongside CEO to evaluate
strategic initiatives.
McKinsey & Co., Palo Alto, CA
Developed analytic models and
recommended an investment plan
for improving women’s health as
a part of the strategy for a global
health foundation.
Natera, San Carlos, CA
Product Manager, 2009-2013
One of the first employees at Natera,
a diagnostics company focused on
improving maternal and fetal health
through genetic insights. Led crossfunctional decision-making across
engineering, marketing, and sales to
develop a suite of prenatal genetic
testing products. Managed workflows
across a team of 12 to ensure products
and strategy were executed effectively
and within executive management
and board expectations. Took insights
from the field through sales calls,
conference meetings, and grand
rounds presentations to inform
product strategy and align priorities
across teams.
Moelis & Company, New York, NY
Analyst, Mergers & Acquisitions, 2009-2010
Merrill Lynch & Co., New York, NY
Analyst, Media & Telecom Investment
Banking Group, 2008-2009
11
Dean L. Drizin
Christine Du
dean.drizin.wg15@wharton.upenn.edu
Dartmouth College, Hanover, NH
A.B., Salutatorian, Summa Cum Laude,
Government, 2006
University of Colorado School of Medicine,
Aurora, CO
christine.du.wg15@wharton.upnn.edu
University of California, Los Angeles, CA
B.S., Biochemistry, 2007
Columbia University, New York, NY
M.A., Biotechnology, 2010
An opportunity to leverage my combined
skill set in medicine and management to
improve health care delivery and patient
outcomes.
An opportunity in a strategic or consulting
role focusing on health care.
University of Colorado, Department
of Medicine, Aurora, CO
Co-Investigator, Summer 2014-Present
Implementing system changes via a
multi-disciplinary, multi-hospital quality
improvement initiative to improve the
patient care handoff process.
United States Navy, Bethesda, MD
ENS, MC, USNR, 2011-Present
Medical education funded by the
United States Navy Health Professions
Scholarship Program (HPSP). Upon
graduation, will serve as an active duty
physician in the United States Navy.
KBL Healthcare, New York, NY
Sourced and evaluated potential
transactions; communicated with
senior management of prospective
acquisitions; developed financial models;
drafted letters of intent; prepared
company and investor presentations;
assisted in management of portfolio
companies of KBL Healthcare Ventures
Banc of America Securities, New York, NY
Investment Banking Analyst,
Healthcare Group, 2005-2007
Conducted qualitative and quantitative
financial analyses for the healthcare
services, medical technologies, and
life sciences sectors for M&A, IPO, and
capital raisings. Developed in-depth
quantitative modeling and transaction
experience.
12
Janssen Biotech Inc., Horsham, PA
Experience Commercial Leadership Program
Intern, Summer 2014
Built and piloted specialty pharmacy
provider (SPP) performance dashboards
for 3 brands: Simponi UC, Stelara, and
Zytiga. Developed and identified
leverage points along the patient
fulfillment process for oncology and
immunology strategic imperatives
by working with 4 external partners,
50 key stakeholders spread across
10 business units within Janssen.
Corum Inc., Taipei Taiwan
Sr. Marketing Executive, 2012-2013
Marketing Executive, 2010-2012
Spearheaded the company’s strategic
plans, client management, legal
processes, technical investments; set
global marketing strategy/product
positioning and segmentations, increased
company profits by 400x in 2 years.
Initiated and oversaw new sales
channels and new product indications
in North America, EU, Latin America,
China and Japan, ultimately leading
to an over 20x increase in US sales
revenues in 2012. Developed international business opportunities in 25
countries and planned 50+ product
launches through global partnerships.
Trained, reviewed, and supported
15 field sales reps and 30 distribution
companies worldwide to establish
15 new Fortune 500 accounts, including L’Oreal, Unilever, and Limited
Brands in one year.
David C.
Fajgenbaum, M.D.
david.fajgenbaum.wg15@wharton.upenn.edu
Georgetown University, Washington, DC
B.S., Magna Cum Laude, with Distinction,
Human Sciences, 2007
Oxford University, Oxford, UK
M.Sc., Public Health, 2008
Perelman School of Medicine at the
M.D., 2013
An opportunity to apply my clinical,
research and business experiences
to accelerate drug development for
diseases with significant unmet needs.
Bristol-Myers Squibb, Plainsboro, NJ
Medical Strategy Intern, Summer 2014
Led initiative to identify data gaps and
design strategic projects for company’s
highest-selling oncology drug ($1.4B
in 2013). Developed comprehensive
plan to overcome insurer restrictions
to oncology drugs. Identified a risk to
immuno-oncology field and proposed
risk-mitigation solutions.
Perelman School of Medicine, University
Adjunct Assistant Professor of Medicine,
2014-Present
Member, Center for Orphan Disease
Research/Therapy, 2013-Present
Appointed faculty member in Division
of Hematology/Oncology to conduct
clinical research and lead an international study as Principal Investigator.
Castleman Disease Collaborative
Network, Philadelphia, PA
Co-Founder & Executive Director,
2012-Present
Launched global initiative to accelerate
drug development for Castleman
disease. Published research that
caused a paradigm shift in the model
of pathogenesis. Established $4.5M
partnership with Janssen Pharmaceuticals
to build a first-of-its-kind registry/
natural history study. Direct 12-member
team and 23-member International
Scientific Advisory Board.
Zoe C. Farrell
Danika M. Fry
Jennifer L. Funk
zoe.farrell.wg15@wharton.upenn.edu
Massachusetts Institute of Technology,
Cambridge, MA
B.S., Physics, B.S., Biology, 2009
danika.fry.wg15@wharton.upenn.edu
B.A., Sociology, 2007
M.A., Sociology, 2007
jennifer.funk.wg15@wharton.upenn.edu
Georgetown University, Washington, DC
B.S.B.A., Summa Cum Laude, Accounting, 2008
healthcare businesses through growth
equity investment and effective
management.
An opportunity to advance health care
innovation through effective investment
and strategic advisory.
An opportunity to work on a dynamic
team within health care services, with
responsibility for both clinical operations
and near-term strategy.
Apple Tree Partners, Princeton, NJ /
New York, NY
Performed due diligence for two
investments that closed in Aug/Sep
2014 as part of the firm’s $1.67B fund:
Series A in the opioid treatment space
and Series B in the care coordination
space. Developed healthcare IT
investment thesis based on extensive
literature and field research. Worked
with an entrepreneur-in-residence in
the planning stages of a population
health management start-up.
Marwood Group, New York, NY
Associate, 2013
Analyst, 2011-2012
Performed due diligence for private
equity clients making healthcare
investments. Advised on commercial /
government payor reimbursement
environments, legislative trends, and
Medicare / Medicaid policy changes.
Conducted primary and secondary
market research for 100+ projects
in numerous healthcare subsectors.
Boston Children’s Hospital, Boston, MA
Genetics Researcher, 2009-2010
Conducted genetics research to
understand the orphan disease of
nemaline myopathy. Co-authored
a paper published in a highly regarded
genetics journal.
Wells Fargo Securities, San Francisco, CA
Summer Associate, Healthcare Investment
Banking, Summer 2014
Provided M&A advisory to specialty
pharmaceutical, medical device, and
biotechnology companies. Developed
marketing materials, conducted diligence, developed presentation materials,
and provided process updates to client
during a sell-side divesture. Worked
with a biotechnology company’s
C-suite to perform diligence for a
private placement, and draft S-1
for confidential IPO filing. Performed
valuation analyses using public
comparables, precedent transactions,
and DCF.
Accenture, San Francisco, CA
Consultant, 2010-2013; Analyst, 2007-2009
Advised healthcare, pension, and technology firms on organization design,
training needs, and communication
development. Select engagements: 1) created a project plan to drive
reorganization of Biomedical Technology
and Philanthropy business units for a
29-hospital system. Negotiated biomed
union contracts and directed relevant
meetings with site management,
hospital administration, and HR.
Convinced 10 separate foundations
to transfer funds to a consolidated
account to achieve financial and
managerial efficiencies; 2) engaged
client executives across multiple business
units to gain buy-in for an organization
change strategy; 3) managed crossborder team to develop and deliver
training courses to internal and external
stakeholders of a public pension fund.
DaVita Healthcare Partners, Denver, CO
Redwoods Summer Associate, Summer 2014
Led a project exploring upstream patient
education opportunities within hospitals. Determined how new kidney
patients are educated today on their
choices while in the hospital, through
extensive secondary research and
a dozen hospital visits across the
country. Designed two in-hospital
patient education programs that
are now being piloted.
The Bridgespan Group, Boston, MA
Senior Associate Consultant, 2011
Strategy consultant for non-profit
clients, with a focus on public health.
Worked with several public health
foundations to define their five-year
investment strategy at the enterprise
and initiative levels. Mentored and
managed two junior teammates and
was recognized as a finalist for officewide “Coach of the Year” award.
Bain & Company, Chicago, IL
Senior Associate Consultant, 2010-2011
Associate Consultant, 2008-2010
Strategy consultant across sectors,
with healthcare clients in hospital
services, pharmaceuticals, and claims
administration. Project examples
include cardiac service line and
outpatient expansion strategies,
merger integration, and process
redesign for financial forecasting.
13
Jin Ge
Daniel E. Geoffrion
Jeffrey S. Goodman
jin.ge.wg15@wharton.upenn.edu
Princeton University, Princeton, NJ
B.S.E., Magna Cum Laude, Phi Beta Kappa
Chemical Engineering, 2008
M.D. Candidate, Alpha Omega Alpha, 2015
daniel.geoffrion.wg15@wharton.upenn.edu
B.A., Economics, 2010
jeffrey.goodman.wg15@wharton.upenn.edu
Harvard University, Cambridge MA
A.B., Cum Laude, Economics, 2009
An opportunity to combine my clinical
and business experiences to transform
care delivery to improve quality and
outcomes.
An opportunity to apply my strategy
experience to an operational role that
gives patients access to quality services
and/or devices.
An opportunity to help lower middlemarket healthcare services companies
develop into industry leaders.
Kaiser Permanente, Oakland, CA
Performance Excellence Intern, Summer 2014
Developed metrics to measure end-oflife quality at KPNC hospice agencies.
Conducted chart reviews and analyzed
variations in cost and outcomes at
KPNC medical centers to develop clinical
best practices.
Medtronic, Minneapolis, MN
Corporate Strategy Summer Associate,
Summer 2014
Developed growth strategy for
Integrated Health Solutions to quintuple
revenue by 2018. Conducted deep
dives in 6 European countries to
understand how patients and money
flow through each healthcare system
in order to best position and communicate value of Medtronic’s solutions
portfolio.
Becton-Dickinson Diagnostics,
Franklin Lakes, NJ
Strategy and Development Intern,
Summer 2014
Researched innovation thesis to serve
the biobanking industry. Modeled
costs, value creation potentials, and
revenue potentials for major players
in the sector.
AirCare, Philadelphia, PA
Business Associate, 2013-2014
Assisted in fundraising activities for
AirCare, a health IT startup focused
on developing a communications and
remote monitoring platform to reduce
hospital readmissions for patients
with CHF.
The Boston Consulting Group,
New York, NY
Developed a brand revitalization plan
for a biopharma in the nutritional space.
Identified cost-savings opportunities
in the post-merger integration of
preclinical and PK/PD units of two
biopharmas. Evaluated new product
launch plans for a med-tech company,
calculated an economic impact of
$400M.
14
Boston Consulting Group, Detroit, MI
Enabled executives to solve key
strategic issues. Projects led to the
initiation of a hospital system merger
($7B combined revenue), sale of an
auto supplier business unit ($500M
revenue), consolidation of 31 equity
portfolios ($40B AUM), and delayering
($20M savings) of a consumer goods
company. Responsibilities included
creating models, evaluating potential
targets, market sizing, designing
decision trees, developing strategic
rationale, and communicating with
executives.
athenahealth, Watertown, MA
Identified, researched, and assessed
200+ prospective healthcare technology
partnerships/acquisitions as part
of athena’s strategy to build out its
inpatient revenue cycle and clinical
software solutions. Met with management teams of 35 companies to evaluate
their best-of-breed technology-enabled
services. Presented analysis and
recommendations on how select
partnerships may support athena’s
effort to address key hospital pain
points.
Waud Capital Partners, Chicago, IL
Evaluated and assessed control-oriented
growth equity investment opportunities
in healthcare, business, and consumer
services out of the firm’s $463M Fund III.
Collaborated with team of investment
professionals to close one platform
investment, five add-on acquisitions,
and two portfolio company debt
financings. Partnered with management
teams of portfolio companies to create
business strategy, assess and structure
strategic acquisitions, access financing
sources and develop corporate
governance as a board observer.
New York, NY
Analyst, Mergers & Acquisitions Group,
2009-2011
Contributed to client acquisition
strategy through financial analysis,
valuation assessment, and company
due diligence, resulting in four
closed transactions.
Seema A. Gunda
Jonathan D. Hahn Miles Hammond
seema.gunda.wg15@wharton.upenn.edu
B.A., Chemistry, 2009
jonathan.hahn.wg15@wharton.upenn.edu Brown University, Providence, RI B.A., Commerce, Organizations and
Entrepreneurship, 2010
miles.hammond.wg15@wharton.upenn.edu
B.A., History, 2007
An opportunity to improve patient
care through life sciences strategy.
Genzyme, A Sanofi Company,
Cambridge, MA
Led initiative to define Genzyme’s
investment strategy in Multiple
Sclerosis symptoms by prioritizing
conditions and conducting a comprehensive asset scan. Collaborated with
R&D, Medical Affairs, Commercial
Operations, and Market Access.
Approach to be leveraged in multiple
business units.
An opportunity to build, grow, and
improve health care through strategy
or operations.
An investing role with exposure to
health care.
Leerink Swann, New York, NY
Consulting Associate, 2011-2013
Consulting Analyst, 2009-2011
Strategy consultant for pharmaceutical,
biotechnology, medical device, and
financial clients with life sciences
assets. Experience includes creating a
loss of exclusivity strategy for a global
pharma client. Built complex modeling
tool to assess economic impact of
various pricing scenarios on key
accounts, resulting in ~10% revenue
increase. Managed a team of five on
a group-wide initiative to improve
efficiency and overall experience of
consulting group.
Sanford C. Bernstein, New York, NY
Research Associate, Summer 2008
Authored 35-page report on value
of high-end consumer care products
relative to low-end substitutes and
impact on sector leaders during
recession. This report was distributed
to 200+ clients and presented in
firm-wide meeting.
Analytics Strategy Intern, Summer 2014 Assessed athena’s analytics strategy
for large enterprise clients and reviewed
internal and external capabilities
to meet anticipated demand. Built
proof-of-concept reporting product,
piloted prototype to hospital executives,
and created roadmap for late 2014
implementation. Conducted client
interviews, identified potential customer
segments, and created internal sales
message.
Amundsen Group – an IMS Health
Company, Burlington, MA
Advised top 10 pharmaceutical
companies on more than 15 projects
focused on market access, marketing
strategy, and pricing/reimbursement
issues. Responsibilities ranged from
client management to project
management to heavy data analysis
and modeling. Managed implementation
of novel analytics process and led
communication across multiple
business units, tech divisions, and
external vendors for multi-billion
dollar respiratory portfolio. Analyzed
marketing strategy and recommended
initiatives focused on patient acquisition.
Created new hire training program,
led case simulations, and streamlined
onboarding process for new hires,
leading to a two-thirds reduction in
training time.
Glenhill Capital, New York, NY
Summer Research Analyst, Summer 2013
Identified and analyzed long/short
equity investments in healthcare,
industrials, and telecom at a bottomup fundamental long/short equity
hedge fund with $1.6B AUM. Worked
directly with Head of Research to
execute and monitor 4 investments
during 12-week internship.
Enhanced Equity Funds, New York, NY
Contributed to all aspects of investment
process at a healthcare private equity
firm with $600M under management,
which invests in lower middle market
healthcare services companies.
Participated in 15 transactions across
4 platforms and served on the Board
of Primary Care Associates, a chain of
primary care clinics acquired in 2012.
Barclays, New York, NY
Health Care Investment Banking Analyst,
2008-2010
Covered companies across life sciences,
healthcare services, and managed care.
Contributed to several closed transactions, including Sole M&A advisory on
Abbott’s acquisition of Solvay pharma
for 4.5B in 2012. Ranked in top bucket
during three out of four review cycles.
15
Elizabeth C. Hansen
Andrew D. Hedin
Roberto L. Hernandez
elizabeth.hansen.wg15@wharton.upenn.edu
Williams College, Williamstown, MA
B.A., Cum Laude, Economics and Biology 2010
andrew.hedin.wg15@wharton.upenn.edu
B.A., Biological Basis of Behavior, 2007
roberto.hernandez.wg15@wharton.upenn.edu
University of Florida, Gainesville, FL
B.S., Cum Laude, Computer & Electrical
Engineering, 2007
A direct investing opportunity with
An opportunity to operate and invest
in innovative health care companies
through venture capital or private equity.
An opportunity to solve challenging
financial, operational and strategy
problems within health care.
Health Essentials LLC, Santa Ana, CA
MBA Operations Intern, Summer 2014
Worked directly with the management
team of the healthcare services venturebacked company. Collaborated with
clinical, operations, IT, and finance
as a project manager to launch dual
eligible coordinated care product.
Assessed population health software
vendors and led RFP process.
Palo Alto, CA
Summer Associate, Technology Investment
Banking, Summer 2014
Provided M&A Advisory for technology
companies. Analyzed strategic
acquisitions opportunities including
redomiciling targets. Managed buy-side
process and developed management
presentations for a leading financial
technology firm. Performed accretion/
dilution and valuation analysis using
public company comparables, precedent
transactions, LBO, and discounted
cash flow.
Putnam Investments, Boston, MA
Equity Research Intern, Summer 2014
Conducted fundamental due diligence
on public and private healthcare
IT companies through product
demonstrations, attending industry
conferences, HQ visits, hosting company
meetings, and expert calls; developed
market and company models.
Clarion Healthcare, LLC, Boston, MA
Advised a wide range of clients from
biotechs to multinational pharmaceutical
companies, contract sales organizations,
medical device companies, and private
equity and venture capital investors.
Project work included due diligence /
strategic transaction support (for
manufacturers’ BD/New Products
groups and PE/VC investors), sales
force strategy and implementation,
marketing innovation recommendations, and managed care strategy.
Focused extensively on the quality
of care incentives that providers are
facing as a result of healthcare reform
and their implications for healthcare
manufacturers and investors.
Fidelity Biosciences, Cambridge, MA
Senior Analyst, 2012-2013
Analyst, 2010-2012
Executed 16 new investments and
9 follow-on investments in biotech,
medical device, healthcare IT, and
healthcare services companies for a
venture capital fund with $1B under
management. Led strategic, technical,
regulatory, market, and financial due
diligence efforts. Invested in private
startup companies (Series A – Series D)
focused on healthcare IT, ultra-rare
diseases, novel technologies in emerging
markets, specialty hospitals, cancer,
ophthalmology, dermatology, and
hospital equipment. Served as board
observer for two portfolio companies.
Leerink Partners, Boston, MA
Analyst, 2007-2009
Advised life sciences clients in over
20 consulting engagements in clinical
development strategy, commercial
opportunity assessments, M&A
strategy, product life cycle management, and competitive landscape
analysis.
16
Harris Corporation, Washington, DC
Project Manager, Dept. of Veterans Affairs,
Veterans Health Benefit Enrollment
Innovation Project, 2013
Reduced delays in the enrollment and
processing of veterans’ health benefits
by designing, testing and deploying
improved software tools. Achieved
15.3% ROS, exceeding management’s
expectation of 12%, by effectively
managing an 8 member team of
analysts, software developers, and
test engineers.
Business Development Manager,
Healthcare Solutions Team, 2010-2013
Built and fostered my organization’s
relationship with the US Coast Guard’s
Medical Division and guided that
relationship to an $11M contract
award to provide our EMR installation
and maintenance services. Engineered
the technical specifications and features
of a cloud-based electronic health
record solution as a member of a
multi-disciplinary team of engineers
and medical specialists.
Luis M. Jones
Ford Kerr
Michael J. Kramarz
luis.jones.wg15@wharton.upenn.edu
B.S., Biomechanical Engineering, 2006
M.S., Mechanical Engineering, 2008
ford.kerr.wg15@wharton.upenn.edu
Colorado College, Colorado Springs, CO
B.A., Cum Laude, Philosophy, 2007
michael.kramarz.wg15@wharton.upenn.edu
Duke University, Durham, NC
B.S.E., Summa Cum Laude, Phi Beta Kappa,
Biomedical Engineering, 2010
M.D. Candidate, Alpha Omega Alpha, 2015
An opportunity to solve challenging
problems in the health care industry.
An opportunity requiring entrepreneurial
and strategic thinking within the
context of mobile health, companion
diagnostics, or other disruptive forces
with potential to make a significant
impact on the health care industry.
An opportunity to build leading
health care companies using my
expertise in medicine and business.
McKinsey & Company, Atlanta, GA
Managed materials workstream on
healthcare project that involved
creating and monitoring a war room,
tracking key process metrics, and
implementing process improvements
in order to assist the client in meeting
critical product delivery dates.
Medtronic Spinal & Biologics, Memphis, TN
Senior Product Development Engineer,
2010-2013
Designed and developed innovative
instruments to facilitate the insertion
of spinal implants by collecting and
analyzing feedback from surgeons.
Led cross-functional team on strategic
projects to develop custom implants in
order to improve the lives of patients
and convince competitive surgeons to
adopt Medtronic products. Completed
the Medtronic Emerging Leader
Program (participants are chosen
through a rigorous selection process
that identifies high performing
employees).
Covidien Neurovascular, Irvine, CA
Quality Engineering Team Lead, 2008-2010
Managed team of engineers and
technicians that provided focused
quality support on micro catheters
production lines. Implemented process
improvements through the execution
and timely closure of nonconformance
reports, maintenance and analysis of
statistical process control charts, and
completion of process validations on
new equipment and fixtures.
Fitly, Philadelphia, PA
Co-Founder and CFO, Summer 2013-Present
Developed launch strategy, raised
$210,000 in seed funding, established
strategic partnerships, and launched
the company. Designed/implemented
supplier operating model in 2 stores
in 2 months, establishing a delivery
radius across 68 zip codes. Awarded
admission into 3 competitive startup
accelerator programs and won the
Wharton Venture Award.
Booz & Company, Washington, DC
Senior Consultant, 2013
Strategy consultant for pharmaceutical,
biotechnology, and payer clients with
project experience in strategic launch
planning, strategic capability assessment
and design, companion diagnostics
strategy, pipeline asset evaluation,
post-merger integration, and commercial opportunity assessments in the
digital/mobile health space.
Entre Todos (Microfinance Company),
Buenos Aires, Argentina
Loan Officer, Internal Consultant, 2009-2010
Worked as a loan officer with a portfolio
of 70+ clients, developed/implemented
client training programs to teach foundational business skills, and co-led
the 6-month restructuring of a private
microfinance firm.
Celgene Corporation, Warren, NJ
Strategy Intern, Summer 2014
Worked in a strategy role within
Celgene Cellular Therapeutics (CCT),
a wholly owned subsidiary of Celgene
Corporation. Constructed long-range
plan for Organ & Tissue Therapeutics
division. Assessed next-generation
opportunities for placental-derived
regenerative medicine platform.
Analyzed specific growth strategy
for CCT’s umbilical cord blood bank,
LifebankUSA.
HealthpointCapital, New York, NY
Intern, Summer 2013
Performed clinical due diligence for
$35M acquisition target, assessing
technology’s efficacy and indications.
Analyzed the competitive landscape,
detailing competitors’ products, pricing,
and market positions. Developed
materials for and participated in
Scientific Advisory Committee meeting
regarding the acquisition.
Children’s Hospital of Philadelphia,
Philadelphia, PA
Research Fellow, Summer 2011
Conducted clinical research in the
Department of Neurosurgery resulting
in poster presentation at annual
American Association of Neurological
Surgeons meeting and publication in
Neurosurgery. Authored three textbook
chapters on pediatric neurosurgical
topics published in Pediatric Cancer,
Spine Surgery Basics, and Neurosurgical
Post-Operative Monitoring and
Complications.
17
Lindsay E.Y. Kuo,
M.D.
lindsay.kuo.wg15@wharton.upenn.edu
Massachusetts Institute of Technology,
Cambridge, MA
B.S., Biology, B.S., Literature, 2006
Northwestern University Feinberg School
of Medicine, Chicago, IL
M.D., 2010
An opportunity to apply clinical and
business knowledge to advance the
quality of care patients receive.
Center for Surgery and Health
Economics, Department of Surgery,
Research Fellow, July 2013-Present
Performed outcomes research, primarily
focused on endocrine surgery, and health
services research. Received a research
grant from the Society of American
Gastrointestinal and Endoscopic
Surgeons. Presented at national
meetings. Multiple publications
published in peer-reviewed journals.
Department of Surgery, Hospital
of the University of Pennsylvania,
Philadelphia, PA
Resident in General Surgery, 2010-Present
Responsible for all aspects of pre-,
intra- and post-operative care. Currently
at the post-graduate year 5 level.
Responsibilities include operating,
daily patient care decision-making,
and communicating with patients/
families. Responsible for leading the
inpatient care team, including multiple
junior residents and mid-level providers.
Experienced in surgical critical care
and cardiovascular surgical critical
care. Experienced in diagnosis and
treatment of vascular, thoracic,
endocrine and oncologic, bariatric,
colorectal, minimally invasive, trauma,
and general abdominal surgery.
Responsible for medical student
teaching integrated into all aspects
of clinical surgery.
18
Jonathan M. Lanznar
Christina S. Liao
jonathan.lanznar.wg15@wharton.upenn.edu
Emory University, Atlanta, GA
B.A. Psychology, 2008, Phi Beta Kappa
christina.liao.wg15@wharton.upenn.edu Massachusetts Institute of Technology,
Cambridge, MA
S.B., Brain and Cognitive Sciences, 2008
An opportunity in strategy and business
development at a growth stage healthcare services or technology company.
An opportunity to improve the quality,
efficiency, and experience of patient
care at an integrated health system.
Quantia Inc., Waltham, MA
Strategy and Business Development
Associate, Summer 2014
Developed the go-to-market strategy
for a new product targeting high-value
medical technology companies and
managed the initial sales team rollout.
Created models to project the market
size and value of additional physician
members; presented to executive
team and insights incorporated into
fundraising strategy. Executed a
segmentation of clients and identified
opportunities to reprioritize sales,
marketing and partnership targets.
Cedars-Sinai Health System,
Los Angeles, CA
MBA Intern, Clinical Transformation,
Summer 2014
Led 15-member cross-disciplinary task
force in developing the strategy and
tactical roadmap for managing financial
and clinical risk in new payer contracts.
Designed pilot program for e-visits and
presented recommendations to
Medical and Clinical Directors to
gain operational buy-in.
InterbrandHealth, New York, NY
Senior Consultant, 2013
Managed brand development programs
with cross-functional teams for 15+
clients across the healthcare industry.
Programs ranged from product
launches to mergers and acquisitions.
Example projects include: creating
the integration strategy for the merger
of two medical device companies,
coordinating the rollout of a new
strategy for a diagnostic services
company while growing the account
from $600,000 to $2M, and consolidating
a headache market segmentation to
identify core prime prospects to
achieve an $18M yearly growth target.
Monitor Group, Los Angeles, CA
Senior Consultant, Life Sciences, 2011-2013
Consultant, Life Sciences, 2010-2011
Advised top 10 pharmaceutical, biotechnology, and medical device clients
on marketing and organizational
strategies. Developed various product
positioning, segmentation, and physician
messaging strategies for pre-launch
and in-line products. Designed and
launched a global Center of Excellence
in access and reimbursement for a
$15B biotechnology firm.
The Walt Disney Company, Burbank, CA
Financial Analyst, Business Planning &
Development for Parks & Resorts, 2008-2010
Conducted financial modeling and
due diligence research on potential
acquisition targets in the travel and
leisure sector. Led market sizing,
profitability benchmarking analysis,
and consumer segmentation for
annual business line reviews with
more than 20 finance and operations
leaders.
David E. Light
Ethan I. Lipkind, J.D.
Patricia J. Liu
david.light.wg15@wharton.upenn.edu
Princeton University, Princeton, NJ
A.B., Magna Cum Laude, Chemistry, 2007
ethan.lipkind.wg15@wharton.upenn.edu
Northwestern University, Evanston, IL
B.A., Political Science, Slavic Studies, 2006
Boston University School of Law, Boston, MA
J.D., 2009
patricia.liu.wg15@wharton.upenn.edu
B.S., Magna Cum Laude, Management
& Operations Management, 2010
An opportunity to grow a company
in the wellness, nutrition or biopharmaceutical sectors through a direct
investing, strategy or operations role.
An opportunity to create value for
healthcare businesses through private
equity investing or strategy role.
Cressey and Co., Chicago, IL
Engaged in all aspects of healthcare
services investment processes including
due diligence, modeling, and financing.
Advised investment committee on
healthcare services trends and sector
opportunities, leading to 2 new investment theses.
An opportunity to pursue strategy and
marketing to impact consumer health
and nutrition within the retail sector.
Biogen Idec, Cambridge, MA
New Product Commercialization Intern,
Summer 2014
As a member of the launch strategy
team for an asset in Phase III, led a
project to develop a strategy and
identify tactics to improve the efficiency of diagnosis of a rare, neuromuscular condition. Worked with
cross-functional internal partners,
sourced and managed external
consultants, conducted primary
research, and presented recommendations directly to division Vice President.
Putnam Associates, Burlington, MA
Analyst, Associate, Senior Associate,
Led strategic consulting projects for six
top 15 pharmaceutical companies, and
three top 10 biotechnology companies. Areas of project focus include
oncology, hematology, neurology,
infectious disease, and health IT. Project
responsibilities included creation of
detailed forecast models, patient and
physician strategic segmentation for
marketing activities, design of payer
contract terms, recommendation on
tactics for engagement with patient
advocacy, structuring pharmaceutical
distribution contracts, and recommendations on clinical development plans.
As a manager, trained, developed,
and oversaw 30+ junior team members
(~ 4-5 per project).
Merck & Co., Rahway, NJ
Associate Chemist, 2007-2008
Designed and synthesized over 100
novel small-molecule drug candidates
based on structure-activity data and
spectroscopic analyses. Contributed
to patents for two drug candidate
scaffolds.
Complete Healthcare Management,
Chicago, IL
Principal, 2011-2014
Provide legal, compliance, and
management services to physician
practices and hospitals; sample
transaction: formed multi-specialty
group by merging neurosurgery and
interventional radiology physician
practices and launched stand-alone
diagnostic medical imaging center
to capture revenues from new group’s
referrals.
Michigan Rural Healthcare Preservation
Holding Co., d/b/a Michigan Clinic,
Chicago, IL and MI
CEO, Director, 2009-2013
Managed over 400 employees. Oversaw
operations and growth of health care
provider holding company; responsible
for all investment and corporate development decisions. Sourced, financed,
structured, and executed acquisition
of 2 community hospitals. Organized
network affiliations with multiple
physician practices, a research institute,
and a medical school. Turned around
hospital from perennial operating
losses to highest net patient revenues
and earnings in its 60-year history;
doubled hospital assets, increased
operating revenues 154%, decreased
liabilities 45%.
Walmart eCommerce, San Bruno, CA
@WalmartLabs Mobile Strategy Intern,
Summer 2014
Evaluated mobile trends and features
for Walmart to prioritize going forward.
Assessed iPad app performance across
the business portfolio to identify
strengths and pain-points. Hosted
business development meetings with
entrepreneurs interested in partnering
with Walmart in the mobile technology
space. Conducted research across
competitor mobile grocery apps to
understand desired functionality in
preparation for the Walmart To Go
(grocery delivery) app launch.
Deloitte Consulting, New York, NY
Provided strategic and managerial
guidance for companies across both
the health care and retail industries,
with project work focused on customer
and market insights. Sample projects:
1) performing a deep-dive on stakeholder influencers to improve provider
targeting and segmentation for a
pharmaceutical company; 2) enabling
international growth initiatives by
reprioritizing budget allocations and
discretionary spend for a medical
device company 3) analyzing consumer
purchase habits and marketing
effectiveness for an ecommerce
retailer; 4) developing a predictive
scorecard to enable store expansion
for a global retailer.
19
Wei (Lluvy) Liu
Sofya Lyashko
Duncan Mackay
wei.liu.wg15@wharton.upenn.edu
Peking University, Beijing, China
B.A., History, 2009
sofya.lyashko.wg15@wharton.upenn.edu
Novosibirsk State University of Economics
and Management,
Novosibirsk, Russia, B.A., 2005
duncan.mackay.wg15@wharton.upenn.edu
B.S., Cum Laude,
Neuroscience and Psychology, 2007
M.D. Candidate 2015
An opportunity in management
consulting or international business
development focused in healthcare.
An opportunity in pharma/biotech
strategy analysis or health care
consulting.
An opportunity to integrate my medical
and business expertise to improve design
of health care delivery systems.
Shanghai, China
Summer Consultant, 2014
Co-developed subsidiary role classification system and management guidelines
for the governance of overseas
subsidiaries for a leading global ICT
solutions provider head quartered in
China. Conducted benchmark study
on foreign subsidiary management
of 4 global technology conglomerates,
presented findings to the head of
Investment Management Department,
and received high remarks.
McKinsey & Company, Moscow, Russia
Worked with a client team to run
analysis and develop opportunities
to increase revenues.
University of Pennsylvania Health System,
Philadelphia, PA; University of Pittsburgh
Medical Center, Pittsburgh, PA
Sub-Internships in Plastic Surgery,
Summer 2014
Acting intern on plastic surgery service,
treating patients, assisting in surgery
across the spectrum of the plastic
surgical field, including general reconstructive surgery, trauma reconstruction,
breast reconstruction, craniofacial
surgery, cosmetic surgery, and hand
surgery. Active in clinical and basic
science research.
B.Braun Medical, Beijing, China
Key Account Supervisor, 2012
Senior Sales, 2010-2011
Developed sales strategies to increase
market penetration, doubling sales
revenue and market share of previous
year. Designed key account management model to optimize resource
allocation and created performance
improvement initiatives to enhance
sales team productivity. Received full
score in annual performance evaluation
with fast-track promotion and awarded
“Best Sales”, “Early Bird”, “Key Account
Management Champion”, and “Excellent
New Employee”.
Johnson & Johnson Medical,
Beijing, China
Sales Management Trainee, 2009-2010
Managed sales at the largest
cardiovascular hospital key account in
China. Established strategic partnership
with industry key opinion leaders and
enhanced clients’ clinical expertise
with physician education programs.
Awarded “Best Project Execution”.
20
TMK, Moscow, Russia
Head of Financial and Economic Analysis
Department, 2011-2013
Led a team of analysts to perform
analysis of economic and operational
performance of the company with a
$7B revenue for the needs of investors
and management. Built valuation
model for a company’s acquisition.
Developed and implemented plan for
a pre-acquisition debt restructuring.
Ernst & Young, Moscow, Russia
Manager, 2005-2011
Led a team of auditors focused on
serving pharmaceutical companies
and healthcare providers. Awarded
as a manager of the best audit project
in 2010. Achieved 25% reduction in
the project time and 60% growth in
the project’s profitability. Designed
audit procedures that were included
in the monthly emails distribution as
best practices examples. Was elected
by the company’s senior management
to the board of experts.
Friends of NOAH, USA, Hershey, PA
Co-founder, Director 2009-Present
Friends of NOAH USA, (Nurturing
Orphans of AIDS for Humanity), is
a grassroots nonprofit designed to
help communities raise their orphaned
children by providing physical, educational, and psychosocial support to the
extended family network of children
in South Africa who have been orphaned
by AIDS. Co-ran the organization, built
and ran online presence, organized
annual fundraisers, researched and
assessed our practices and outcomes.
To date, we have raised over $120,000
and care for over 250 children.
Bain & Company, Chicago, IL
As a strategy consultant, structured
and performed analyses that drove
impactful recommendations for
Fortune 500 clients. Built financial
models, assessed and recommended
M&A targets, developed research
tools, assessed and implemented
executive culture and communication
improvements.
Amit A. Mahadevia
amit.mahadevia.wg15@wharton.upenn.edu
B.A., Psychology / Behavioral Neuroscience, 2008
Kristen E.
Manderscheid
kristen.manderscheid.wg15@wharton.upenn.edu
B.S., Magna Cum Laude, Economics, 2010
Carlo Martelossi
carlo.martelossi.wg15@wharton.upenn.edu
Bocconi University, Milan, Italy
B.B.A., M.S., Finance, 2011
An opportunity in strategy or
business development at a biotech
or pharmaceutical company.
An opportunity to develop and refine
global pricing and market access
strategies for select pipeline assets.
An opportunity to make an impact
and create value through operational
improvements.
Celgene Corporation, Summit, NJ
Global Marketing Intern, Summer 2014
Designed and executed an NPV
analysis to assess commercial value
of an internal asset and biomarker
strategy in a large lymphoma indication.
Worked closely with clinical team to
design clinical trial scenarios to support
development of asset. Analyzed
development opportunity of a pipeline
asset in a niche lymphoma indication
not currently addressed, including
review of treatment process and
competitive landscape, and recommendation of how to optimize value
of the asset. Created global messaging
platform based on results of a randomized clinical trial and collaborated
with US and global marketing leadership
to validate and deliver messages.
Biogen Idec, Cambridge, MA
Pricing & Reimbursement Strategy MBA
Intern, Summer 2014
Led a project examining the financial
and strategic impact of federally
mandated 340B drug discounts on a
pipeline asset, to inform U.S. launch
planning. Supported the P&RS group
by providing pricing estimates for an
early-stage pipeline asset across three
targeted indications, to inform indication
prioritization and global commercial
forecast. Helped manage an external
vendor conducting primary payer
research in U.S. and Germany, to
understand value drivers and pricing
potential for pipeline drug.
Zalora, Jakarta, Indonesia
Marketing Intern, Summer 2014
Designed and implemented new
processes for promotional campaign
development and customer relationship
management teams, creating new
roles, clarifying responsibilities, and
introducing new incentive schemes.
Developed segmentation for Zalora’s
200,000 customers in Indonesia based
on identified main drivers of purchasing
behavior and launched pilot to evaluate
the effectiveness of newsletters
tailored to customer preferences.
ZS Associates, Boston, MA
Business Associate, 2008-2010
Sales and marketing strategy consultant
for pharmaceutical, biotech, and medical device companies. Managed teams
of associates in conducting qualitative
and quantitative market strategy
engagements. Moderated qualitative
interviews with physicians (across
many specialties) and patients. Designed
and analyzed quantitative research
instruments to inform commercial
strategy.
Deloitte Consulting, Boston, MA
Analyst, 2010-2012
Strategy and operations consultant
focused primarily on pharmaceutical
clients. Responsibilities included
strategic advisement, analytical model
development, process design, and
project management. Major projects
were: future-state design of global
quality control processes within clinical
trial data management; development
of a U.S. brand planning tool to
effectively manage marketing spend
for client’s top 25 U.S. commercial drugs;
and creation of business analytics to
track effectiveness of a global data
compliance project across 57 countries
and 5 third-party vendors.
Milan, Italy
Identified and launched strategic
pricing initiatives in Germany, France,
and Spain for major American medical
device manufacturer as part of the
redefinition of the go-to-market
model leading to $25M bottom-line
impact. Performed competitive analysis
and quantitative assessment of the
Italian Generics market in strategic
due diligence on pharmaceutical
company for top private equity firm.
Defined new customer segmentation
and targeting strategy for top
European corporate and investment
bank based on opportunities for crossselling of high-value-added products
resulting in $50M increase in revenues.
Deutsche Bank, Milan, Italy
Investment Banking Intern, Fall 2010
Managed coverage activities on clients
in the consumer, retail, industrial and
healthcare sectors.
21
Caitlin L. McAuliffe
Lisa E. Perlmutter
Gordon I. Phillips
caitlin.mcauliffe.wg15@wharton.upenn.edu
B.S., Cum Laude, Molecular Cellular
and Developmental Biology, 2005
University of Pennsylvania School of Medicine,
Philadelphia, PA
lisa.perlmutter.wg15@wharton.upenn.edu
Washington University, St. Louis, MO
B.A., College Honors, Psychology, 2009
gordon.phillips.wg15@wharton.upenn.edu
Williams College, Williamstown, MA
B.A., Math & Economics, 2008
An opportunity to apply my medical
and business experience to improve
patient quality of care.
An opportunity in strategy, operations,
or business development to improve
value in health care delivery.
University of Pennsylvania Health
System, Philadelphia, PA
Research Assistant, Department of
Orthopaedic Surgery, 2011-2014
Critically examined precipitating
factors for unplanned admission to
the intensive care unit following
arthroplasty. Spearheaded due diligence
process in preparation for first published
study, simultaneously laying groundwork for multiple subsequent studies,
with ultimate goal of maximizing
patient safety and clinical quality
in joint replacement surgery.
Aetna Accountable Care Solutions,
Hartford, CT
Product Strategy/Market Intelligence Intern,
Summer 2014
Member of team forging innovative
partnerships and insurance models
with providers. Developed business
case and new product concept for
comprehensive at-home care solution
to help providers lower the total cost
of care. Created due diligence model
to evaluate one of Aetna’s business
strategies and the viability of a new
solution in three markets.
A health care finance role in banking,
private equity or business development,
leveraging my prior operational and
strategic experience.
Raymond James, Nashville, TN
Led teams in the execution of multiple
M&A processes, the creation of marketing materials and the underwriting
of $140M in capital raises for middlemarket health care services businesses,
primarily in the behavioral health and
hospice industries. Walter Reed Army Medical Center,
Washington, DC
Research Assistant, Center for Neuroscience
and Regenerative Medicine, 2009-2010
Investigated traumatic brain injury,
spinal cord injury, phantom limb pain
and other sequela of amputation.
Participated in several original research
projects by writing research protocols,
participating in the Institutional
Review Board process, and assisting
with the execution of protocols.
The Advisory Board Company,
Washington, DC
Research Analyst, 2010-2011
Completed four best-practice research
studies and several web conferences
for a client base of 400+ senior hospital
executives. Analyzed primary and
secondary research into actionable
strategies for hospital executives on
topics including clinical quality performance, physician engagement and
contracting, physician leadership
development, ICU management, and
use of advanced practice providers.
Developed tools to help clients
implement best practice strategies,
including ROI analysis of palliative
care and a toolkit for improving
project management skills.
Walter Reed Army Medical Center,
Washington, DC
Clinical Research Assistant, Physical Medicine
and Rehabilitation Service, Summer 2008
Treated multiple amputee patients
with experimental mirror therapy
designed to reduce phantom limb pain.
22
CVS Caremark, Woonsocket, RI
Designed and implemented a new
chain-wide service guiding patients
and doctors through the process of
switching from a 30- to 90-day supply
of select maintenance medications,
increasing prescription drug adherence
by 15% for converted patients and
converting over 1M patients in first
12 months of program operation.
Leveraged this capability to retain
Walgreens patients during the
Walgreens-Express Scripts dispute.
Monitor Company Group, Cambridge, MA
Led teams in the creation of pricing,
growth, and partnership strategies
for a variety of corporations across
the pharmacy, insurance, and pharmaceutical industries. Examples include
the creation of an econometricallyderived Medicare prescription drug
plan pricing strategy for a national
health insurer and prioritizing the
development of pharmacogenomics
revenue streams for a leading
pharmacy benefits manager.
Visali V. Ramanathan
Emily T. Reid
Matthew B. Ritz
visali.ramanathan.wg15@wharton.upenn.edu
A.B., Cum Laude, Molecular & Cellular Biology,
2010
emily.reid.wg15@wharton.upenn.edu University of California, Berkeley, CA
B.A., Honors, Public Health, 2008
matthew.ritz.wg15@wharton.upenn.edu
Georgia Institute of Technology, Atlanta, GA
B.S., Highest Honors, Management, 2007
An opportunity to identify and build
successful life sciences companies
through a business development or
investing role.
An opportunity to build and grow
a health technology company.
Castlight Health, San Francisco, CA
Product Marketing Intern, Summer 2014
Partnered with the Product and Sales
teams to develop collateral for recent
and upcoming product releases. Drove
the creation and operationalization of
customer case studies in coordination
with Sales Senior Leadership, Corporate
Marketing, and Customer Success.
Cornerstone Investment Partners,
Atlanta, GA
Performed fundamental analysis
of domestic equities for $9B fund.
Constructed buy, sell, hold, and pass
recommendations for 30+ stocks,
and presented them to the portfolio
managers.
Omada Health, San Francisco, CA
Business Development Consultant,
Summer 2013
Collaborated with Co-Founders, VP of
Marketing, and VP of Sales to develop
a multi-year business plan strategy:
outlined sales process and target
market, and developed pricing strategy. Assessed market competition and
product positioning, and established
strategic partnerships with wellness
companies and benefits consultants to
leverage synergies among product and
service offerings. Tiger Global Management,
New York, NY
Analyst Intern, Spring Semester 2014
Worked 10-20 hours per week during
the spring semester. Conducted primary
research, reference checks and built
financial models for equity investment
ideas in various industries.
Genentech Inc., South San Francisco, CA
Assisted deal teams in four licensing,
acquisition, and collaboration deals by
conducting scientific, legal and financial
due diligence, drafting term sheets,
and supporting negotiations in
Immunology and Infectious Diseases
spaces. Evaluated potential partnerships
and deal structures to enable
microbiome research and presented
recommendations to senior leadership.
Frankel Group LLC, New York, NY
Senior Associate, 2012-2013
Analyst, 2010-2011
Provided strategic recommendations
to guide pharmaceutical and biotech
companies’ global R&D investments.
Developed 9-year renal disease business
strategy totaling $8B in revenue for
Fortune 50 pharmaceutical company;
analyzed market research and secondary
data to develop $2B revenue model
for immune-based renal diseases.
Created investor presentation for
a development stage biotech and
collaborated with CEO to determine
differentiating properties of novel
drug and appropriate level of clinical
data disclosure for a non-scientific
audience. Led team in conducting
150 primary interviews targeting
physicians, patients, and payers;
synthesized findings to develop
orphan disease business strategy for
Fortune 50 pharmaceutical company.
Mercer, San Francisco, CA
Senior Associate, 2013
Analyst, 2008-2010
Consulted self-funded employers (ranging from 2,000 to 150,000
employees) in solving major healthcare
service, cost, and administration issues.
Proposed solutions to address the
short and long term implications
of healthcare reform, and managed cross-functional teams of experts in
law, pharmacy, and wellness as well
as vendor account managers and
implementation leads. Led the West
Coast offices in Data Warehouse
& Healthcare Analytics sales and
implementations.
NCDR, LLC (dba Kool Smiles), Atlanta, GA
Business Development Manager, 2012-2013
Senior Financial Analyst, 2010-2012
Led team of 7 during pilot and expansion
of orthodontic program. Created
pricing, roll-out, and capital spending
strategies and presented recommendations to executive management team.
After receiving approval, grew program
from pilot in 2 offices representing
$200,000 of revenues to 14 offices
representing $2M of revenues in 6
months.
Summit Partners, Palo Alto, CA
Originated and executed healthcare
private equity investments. Led
reimbursement, market, regulatory,
and financial due diligence efforts.
Conducted primary interviews, wrote
investment memorandums, and modeled deal return scenarios. Originated
11 Letters of Intent representing $1B
of Summit Partners’ capital.
23
Charlie A. Robinson
Alexander V. Rupert
Ankit Saxena
charles.robinson.wg15@wharton.upenn.edu
University of Pennsylvania,
College of Arts & Sciences, Philadelphia, PA
BA, Cum Laude, English, 2008
alexander.rupert.wg15@wharton.upenn.edu
Dartmouth College, Hanover, NH
A.B., Summa Cum Laude, Chemistry and
Psychology, 2007
ankit.saxena.wg15@wharton.upenn.edu
Indian Institute of Technology (IIT),
New Delhi, India
Dual Degree Bachelor and Master of Technology,
Biochemical Engineering & Biotechnology, 2009
An opportunity to improve healthcare
delivery through innovations in care
management, informatics, patient
engagement, data connectivity, and
insurance programs.
An opportunity with a hedge fund
investing across the capital structure.
An opportunity to improve the interactions
among various stakeholders within the
healthcare value chain.
Aetna Accountable Care Solutions,
Boston, MA
Product Strategy Intern, Summer 2014
Developed product concept to
support accountable care organizations,
including recommendations for technology utilization, partnerships, and
implementation; supported development
of external partnerships designed to
enhance accountable care organizations.
The Advisory Board Company,
Washington, DC / Austin, TX
Dedicated Advisor, Performance
Technologies, 2011-2013
Worked on a team that launched
a new business intelligence tool
designed to empower a data-driven
approach to physician network
development; analyzed large data
sets, developed work plans, and
provided execution support for
program improvements.
Associate, Analyst, & Senior Analyst,
Research & Insights, 2008-2011
Developed hospital strategies for clinical
technology adoption and specialty
program development; used pro-forma
modeling to inform technology and
infrastructure investments; led a team
specializing in minimally invasive surgery,
obesity, and chronic disease management.
Wharton Center for Health Management
& Economics, Philadelphia, PA
Researcher, 2007-2009
Explored success and failure of venture
capital-funded healthcare companies;
published article in Health Affairs,
January 2009.
24
King Street Capital Management,
London, UK
Summer Associate, 2014
Generated investment ideas in the
paper and packaging and European
airlines spaces, presenting recommendations to the Investment Committee.
Met with management teams and
consulted industry experts to discover
business risks and opportunities.
Created detailed operating models
and analyzed capital structure
alternatives including rights offerings.
Taconic Capital Advisors, New York, NY
Worked with fund Partners on distressed
credit opportunities and long-short
equity positions. Developed recovery
model to determine value of unsecured
claims at various entities in the
American Airlines capital structure.
Investigated Monster Beverage Corp’s
convenience store sales strategy to
model growth opportunity. Assessed
widespread media reports regarding
health hazards associated with energy
drinks. Research led to a $50M equity
long position.
The Blackstone Group, New York, NY
Analyst, 2009-2011
Collaborated with management teams
of automotive and insurance companies
to create financial models and business
plans for corporate restructurings.
Formulated strategies to negotiate
with stakeholders and regulators.
J.P. Morgan, New York, NY
Analyst, 2007-2009
Performed credit reviews for J.P.
Morgan’s technology, media, and telecommunications loan portfolio. Wrote
a weekly update for report to CEO on
restructuring situations.
Strategy& (formerly Booz & Company),
New York, NY
Analyzed network strategy at a major
health insurer to achieve 15% medical
cost saving for launch of a $5B consumerdirected business. Developed hypothesis
and analysis framework for savings in
Durable Medical Equipment, and
Specialty Care Services.
SQZ Biotechnologies, Boston, MA
Marketing Head, 2013-2014
Developed two-part marketing strategy:
1) Outbound marketing initiatives such
as vendor shows that resulted in 30
active customers within first 8 months
of operations; 2) Inbound marketing
initiatives via SEO and customer analytics
(impressions, click-through rate, and
conversions), that resulted in 2x
growth in traffic in 2 months.
Novartis Vaccines & Diagnostics,
Raleigh, NC
Global Value Chain Manager-Influenza
Portfolio, 2011-2013
Global Technical Leadership Program
Led planning, execution and issue
management for portfolio comprising
6 influenza vaccine products accounting
for 25% of revenue for the division.
Managed cross-functional projects
in supply chain, manufacturing,
engineering, and finance across
U.S.A., U.K., Italy, India, and Germany.
Matthew L. Schulz
matthew.schulz.wg15@wharton.upenn.edu
Carnegie Mellon University, Pittsburgh, PA
B.S., University Honors, Business Administration
(Finance), 2008
An opportunity with a private equity
fund investing in the healthcare sector.
Teladoc, Greenwich, CT
MBA Associate, Summer 2014
Constructed business plan and projection
model for a contemplated behavioral
health product offering. Assessed
acquisition opportunities and evaluated
new revenue models. Sourced potential
investors and negotiated term sheets
for Series F fundraise.
Altaris Capital Partners, New York, NY
Assessed and executed new healthcare
acquisition opportunities. Drafted
transaction documents, arranged debt
financing, managed diligence work
flow, and built investment models.
Monitored existing portfolio companies
by attending board meetings,
performing valuation analyses, and
reviewing strategic opportunities with
management. Assisted in fundraising
process for Altaris’ third fund. Closed
four deals including two LBOs, one
add-on, and one exit.
Leerink Partners / Merrill Lynch,
New York, NY
Analyst, 2008-2011
Analyzed equity, equity-linked and
debt financing alternatives, merger
consequences, private equity investments, and IPO scenarios for companies across the healthcare industry.
Joined a group of over 20 investment
bankers from Merrill Lynch who
assumed leadership of the investment
banking platform at Leerink Partners.
Closed four deals including three M&A
transactions and one equity offering.
Bedir W. Shather,
M.D.
Adam R. Sinensky
adam.sinensky.wg15@wharton.upenn.edu
B.S.E, Magna Cum Laude, Bioengineering, 2005
bedir.shather.wg15@wharton.upenn.edu
University of Leeds Medical School, Leeds, UK
M.D., 2009
Imperial College London, London, UK
B.Sc. Medical Sciences and Management, 2007
An opportunity to help build an
innovative health care company
through a business development role.
A role blending strategy and operations
for a provider focused healthcare
IT solution.
J.P. Morgan, San Francisco, CA
Summer Associate in Health Care
Investment Banking, Summer 2014
Advised clients in the biotechnology,
medical devices and diagnostics industries. Performed financial analyses including DCF and trading comparables
for an $80M private placement round
for an innovative diagnostics company.
Performed sum of the parts DCF valuation as part of a defense strategy for
an $8.9B biotechnology company. Led
the creation of a buy-side M&A ideas
pitchbook, conducting due diligence
on over 30 potential acquisition
targets for a $1.2B biotechnology
company.
Valence Health, Chicago, IL
Product Definition Intern, Summer 2014
Established standard operating
procedures for demonstrating suite
of health provider IT products to
customers. Wrote requirements
documentation for development of 5
new product features leveraging Agile
process. Supported upcoming product
user experience overhaul, including
development of user personas and
interface redesign.
Life Technologies, San Diego, CA
& London, UK
Associate to the Chief Medical Officer,
2012-2013
Part of a clinical team tasked with
identifying target areas for product
development. Worked with R&D team
to build models to identify target
biomarkers, leading to the creation
of 3 oncology panel tests used by a
number of academic medical centers.
Led the development of a clinical
marketing campaign for the company’s first appearance at the ASCO.
National Health Service, London, UK
Senior house physician (resident) 2009-2011
Prioritized, diagnosed, and treated
inpatient admissions across a variety
of specialties in internal medicine
and general surgery. Delivered
clinical results while working to
tight deadlines in a highly pressured
environment.
Navigant Consulting Life Sciences
Advisory Services, New York, NY /
San Francisco, CA
Associate Director, 2013
Managing Consultant, 2010-2013
Commercial and business development
consultant for life sciences organizations.
Managed internal teams and external
relationships for up to 8 concurrent
client engagements. Launched San
Francisco office as day-to-day leader;
integral in growth to 7 employees and
~10% of practice’s revenues within
first year. Led multiple long-term
client relationships, encompassing
multiple follow-on projects.
ZS Associates, New York, NY
Provided sales and marketing strategic
advice to top pharmaceutical and
biotechnology companies. Managed
client relationships and internal project
teams as large as 5-6 employees globally
and officially mentored 3 junior
employees.
25
Tejus B. Ujjani
laura.swearingen.wg15@wharton.upenn.edu
Davidson College, Davidson, NC
tejus.ujjani.wg15@wharton.upenn.edu
Boston University – School of Management,
Boston, MA
B.S., Magna Cum Laude, Business, 2004
businesses through health care
focused private equity investing.
An opportunity to research and evaluate
investments in public and private health
care companies.
An opportunity to further innovation
in healthcare technology, whether as
an investor or operator.
NaviMed Capital, Washington, DC
Worked with founding partner of
healthcare-focused growth equity
fund to manage due diligence process
for an investment in the roll-up of
several healthcare services companies.
Built financial model, developed financing
materials to raise capital and worked
directly with management teams.
Researched industry landscape,
identifying 20+ investment opportunities.
Valo Group, Philadelphia, PA
Investment Analyst Intern,
Summer 2014-Present
Evaluated equity and credit investments in both health care and retail
companies for value-oriented, long /
short hedge fund. Performed market
sizing, researched SEC filings and built
detailed financial models to inform
analyses and provide recommendations directly to portfolio manager.
Longitude Capital, Menlo Park, CA
Built the foundation and investment
strategy for the $710M firm’s newlyformed health IT vertical. Created and
executed a thesis-based deal sourcing
effort by mapping the sector, its
themes, and its 1,000+ companies.
Established the vertical’s advisory
network of 20+ former entrepreneurs,
industry leaders, and investors.
Proactively sourced 8 investment
opportunities and performed due
diligence. Worked directly with partners
and managed two junior interns.
HarbourVest Partners, Boston, MA
Direct Investment Associate, 2011-2013
Sourced, evaluated and monitored
growth equity, buyout, and mezzanine
private equity investments for Direct
Investment Group with ~$1.5B dedicated
capital. Evaluated 150 new opportunities
and performed due diligence, created
financial analyses and presented 13
prospective investments to Investment
Committee, gaining approvals for 5
initial investments (1 healthcare services
company). Active board involvement
on 3 portfolio companies. Completed
2 follow-ons and refinancing for
ReCommunity, creating the largest
independent recycling company in
the U.S.
Wells Fargo Securities, Charlotte, NC
Healthcare Investment Banking Analyst,
2009-2011
Top 10% of analyst class. Analyzed
companies using comparable company,
discounted cash flow, accretion/dilution,
merger and leveraged buyout analyses
for M&A transactions and debt and
equity financings for life sciences
companies.
26
Daniel P.
van den Bergh
Laura G. Swearingen
Deloitte Corporate Finance (Health Care
& Life Sciences Practice), New York, NY
Vice President, 2011 – 2013
Associate, 2008 – 2011
Analyst, 2006 – 2008
Provided financial advisory services to
public and private health care clients
regarding mergers, acquisitions,
divestitures/carve-outs and joint
ventures. Led deal team in advising
not-for-profit health care system ($7B
Revenue) in execution of multiple
acquisitions and joint ventures (e.g.
surgery centers, radiology, radiation
oncology, dialysis, anesthesia, and
group physician practices).
AT&T Corporate, Financial Leadership
Program, Bedminster, NJ
Corporate Finance Specialist, 2005-2006
One of seven undergraduates
recruited nationwide for executive
development program with rotational
assignments. Strategic Venture Fund –
Built valuation models and evaluated
startup companies as potential investments for AT&T’s venture capital fund.
Corporate Strategy - Supported
Director in analyzing business models
around new, confidential media
technologies for CEO, David Dorman.
daniel.van.den.bergh.wg15@wharton.upenn.edu
Cornell University, Ithaca, NY
B.S., Biological Engineering, 2007
Safeguard Scientifics, Wayne, PA
Performed 8 venture capital
deployments and an exit totaling
$850M+ in transaction value in
biopharma, medtech, diagnostics, and
health IT. Performed due diligence
on investment opportunities. Drafted
investment memos and term sheets.
Built financial models and cap tables.
Rebuilt the firm’s backbone capital
deployment and returns model.
Worked with leadership of portfolio
companies on strategic projects.
EuroConsult, New York, NY
Led cross-border M&A transactions for
private equity and Fortune 500 clients
in pharma and medtech. Managed a
team of analysts.
Citigroup, London, UK / New York, NY
Analyst, 2007-2009
Active participant on deal teams
originating and executing M&A
transactions in the healthcare sector
across the U.S., European and emerging
markets.
David S. Wagner
Ying Yang
Rada Yovovich
david.wagner.wg15@wharton.upenn.edu
ying.yang.wg15@wharton.upenn.edu
Fudan University, Shanghai, China
B.A., Economics, B.A., Law, 2007
M.A., Economics, 2010
rada.yovovich.wg15@wharton.upenn.edu
University of Chicago, Chicago IL
AB Fundamentals: Issues & Texts, 2006
An opportunity in strategy or business
development to bridge developed
and emerging markets in the healthcare
industry.
An opportunity focused on innovation
in health care delivery, particularly at
the point of service, with experience in
big data analytics, supply chain, clinical
and non-clinical process improvement,
and revenue cycle.
Fidelity Investments, Boston, MA
Summer Equity Analyst, Summer 2014
Performed fundamental equity analysis
on domestic stocks in the retail sector.
Constructed buy/sell recommendations
for four stocks and pitched them
to portfolio managers. Developed
and presented industry overview
presentation of discount retail sector
to portfolio managers and President
of Equity Division.
PAR Capital Management, Boston, MA
Summer Analyst, Summer 2013
Member of investment team at longshort equity hedge fund with over
$3.5B in assets. Constructed financial
models and performed detailed analyses
by developing bottom-up forecasts
to assess sensitivity to key drivers and
to identify upside/downside potential
of investment opportunities.
Putnam Associates, Boston, MA
Advised leading pharmaceutical and
biotech clients on growth strategies,
therapeutic area strategies, and pricing
and reimbursement strategies, in both
international and domestic markets.
Constructed financial models and
Monte-Carlo simulations to forecast
value of pricing and contracting
strategies, potential biosimilar
competition, and impact of generic
competition. Awarded 2011 Putnam
MVP honor as distinction of top
performance out of all employees.
Novartis AG, Basel, Switzerland
MBA intern, Corporate Strategy,
Summer 2014
Helped with 5-year strategic planning
across all divisions and geographies in
Novartis. Coordinated a global project
on real-world outcomes across US,
Brazil, UK and Germany. Analysis
influenced senior decision making,
changed forecast, and shifted
spending.
McKinsey & Company, New York, NY /
Shanghai China
Associate, 2013
Business Analyst, 2010-2012
Distinctive analyst directly promoted
to Associate and the only transferee
from Greater China to the US in 2012.
Focused on multinational pharmaceutical
companies. Key projects included
commercial excellence (e.g., sales force
effectiveness, marketing strategy),
business development (e.g., M&A
target screening, licensing), and
emerging market strategy (e.g.,
entry and expansion strategy, local
partnership). Extensive field experience
with sales representatives and physicians.
The Children’s Hospital of Philadelphia,
Philadelphia, PA
Summer Intern, 2014
Worked with the VP of Medical Affairs
to develop a program for physician
leadership education, including a
needs assessment, content design,
delivery model, and communication
strategy. Worked collaboratively
to integrate the perspectives of a
comprehensive variety of stakeholders
throughout the academic medical center,
ranging from nurse and physician staff
to the senior leadership team.
Senior Manager, 2011-2013
Supported senior leadership team as
strategic subject matter expert on
revenue cycle big data performance
measurement, analysis, and reporting
across athena client base representing
over 50,000 physicians. Delivered
performance improvement reports,
including implementation plans
and detailed impact projections to
organizations ranging from 2-physician
practices to 93-hospital health systems.
Huron Consulting Group, Chicago, IL
Manager, 2006-2011
Delivered supply chain, materials
management, and strategic sourcing
cost management strategies to senior
leadership teams at client health systems
ranging from single hospitals to 70facility national healthcare institutions.
Conducted cost savings strategies
worth as much as $65M annually
recurring savings, including identification, assessment, implementation, and
ongoing monitoring efforts.
27
2014
Internship Sponsors
The following organizations
provided internships for Health Care
Management Students in Summer, 2014.
AETNA ACCOUNTABLE CARE SOLUTIONS
Boston, MA
Hartford, CT
ALBRIGHT STONEBRIDGE GROUP
Washington, DC
APPLE TREE PARTNERS
Princeton, NJ
ATHENAHEALTH
Watertown, MA
AUGMEDIX
San Francisco, CA
BANK OF AMERICA MERRILL LYNCH
Palo Alto, CA
BECTON DICKINSON
Franklin Lakes, NJ
BIOGEN IDEC
Cambridge, MA
BOOZ & COMPANY (NKA STRATEGY&)
New York, NY
CRESSEY & CO.
Chicago, IL
MOUNT KELLETT CAPITAL MANAGEMENT
New York, NY
DAVITA HEALTHCARE PARTNERS
Denver, CO
NAVIMED CAPITAL
Washington, DC
DELOITTE CONSULTING
New York, NY
NOVARTIS AG
Basel, Switzerland
FIDELITY INVESTMENTS
Boston, MA
PFIZER
New York, NY
FITLY
Philadelphia, PA
PUTNAM INVESTMENTS
Boston, MA
GENENTECH INC.
South San Francisco, CA
QUANTIA INC.
Waltham, MA
GENZYME, A SANOFI COMPANY
Cambridge, MA
RAYMOND JAMES
Nashville, TN
GLENHILL CAPITAL
New York, NY
TELADOC
Greenwich, CT
GOOGLE
Mountain View, CA
UNIVERSITY OF COLORADO,
DEPARTMENT OF MEDICINE
Aurora, CO
HEALTH ENTERPRISE PARTNERS
New York, NY
HEALTH ESSENTIALS LLC
Santa Ana, CA
UNIVERSITY OF PITTSBURGH
MEDICAL CENTER
Pittsburgh, PA
THE BOSTON CONSULTING GROUP
Shanghai, China
HOSPITAL OF THE UNIVERSITY OF
PENNSYLVANIA, CENTER FOR SURGERY
AND HEALTH ECONOMICS
Philadelphia, PA
BRISTOL-MYERS SQUIBB
Plainsboro, NJ
INFOSYS LIMITED
Pune, India
CASTLIGHT HEALTH
San Francisco, CA
JOHNSON & JOHNSON –
JANSSEN BIOTECH INC.
Horsham, PA
WALMART ECOMMERCE
San Bruno, CA
J.P. MORGAN
San Francisco, CA
WELLS FARGO SECURITIES
San Francisco, CA
KAISER PERMANENTE
Oakland, CA
ZALORA
Jakarta, Indonesia
CEDARS-SINAI HEALTH SYSTEM
Los Angeles, CA
CELGENE CORPORATION
Summit, NJ
CELGENE CELLULAR THERAPEUTICS
Warren, NJ
THE CHILDREN’S HOSPITAL
OF PHILADELPHIA
Philadelphia, PA
CITADEL INVESTMENT GROUP
New York, NY
CORNERSTONE INVESTMENT PARTNERS
Atlanta, GA
KING STREET CAPITAL MANAGEMENT
London, UK
LONGITUDE CAPITAL
Menlo Park, CA
MCKINSEY & COMPANY
Palo Alto, CA
Washington, DC
Atlanta, GA
Moscow, Russia
MEDTRONIC
Northridge, CA
Minneapolis, MN
28
UNIVERSITY OF PENNSYLVANIA
HEALTH SYSTEM
PHILADELPHIA, PA
VALENCE HEALTH
Chicago, IL
VALO GROUP
Philadelphia, PA
2014
Health Care Program Mentors
Mentors are leaders and senior managers
in the health care field who have agreed
to provide career and professional
development advice and guidance
to Health Care Management Students.
SEBASTIAN AGUILAR GARCIA
Associate
A.T. Kearney
Mexico City, Mexico
SHEENA ASHOK
Senior Consultant
Kaiser Permanente-Southern California
Permanente Medical Group (SCPMG)
Pasadena, CA
VIKRAM D. BAKHRU, MD
Chief Medical Officer
First Opinion
San Francisco, CA
TONY BALDA
President & COO
Medicomp, Inc.
Melbourne, FL
JOHN BARKETT
Director of Product Marketing
and Policy Affairs
Towers Watson Exchange Solutions
Washington, DC
MEGAN UNTALAN BARKETT
Chief of Staff to CEO
The Advisory Board Company
Washington, DC
PETER R. BARNETT, DMD
President
Star Ranch Dental
Plano, TX
GRANT BECHTOLD
Vice President of Business Operations /
Corporate Development
Medsurant Holdings, LLC
(portfolio company of New Capital Partners)
Denver, CO
RYAN BERGER
Senior Business Analyst
Hearst Health Innovation Lab
Los Angeles, CA
WILLS CHANDLER
Vice President of Health System Alliance
CVS Caremark
Cumberland, RI
ALEXIS BERNSTEIN
Director, Strategy & Operations,
Accountable Care Solutions
Aetna
Boston, MA
DEEP CHARAN, MD
Resident Physician
UCLA
Los Angeles, CA
DEEPA BHAT
Product Manager
Genentech
THIERRY CHAUCHÉ
Executive Director,
Business Planning & Analysis
Novartis Pharmaceuticals
East Hanover, NJ
MITCHELL BLUTT, MD
CEO
Consonance Capital
New York, NY
EMILY COUEIGNOUX CHEN
Senior Manager, Market Planning
Seattle Genetics
Bothwell, WA
DANIEL BRANCO
Founder & CEO
DMBranco Healthcare Investments &
Advisory/Medicinia Digital Medicine
São Paulo, Brazil
MARK CHIN
Vice President
Longitude Capital
Menlo Park, CA
SAM BRASCH
Director
Kaiser Permanente Ventures
Oakland, CA
JOHN BRODSKY
President
Fairmount Capital Advisors, Inc.
Philadelphia, PA
LUCAS BUCHANAN
Executive Vice President,
Corporate Development and
Commercialization; Executive in Residence
Silk Road Medical, Inc.; Warburg Pincus
Sunnyvale, CA
ALEX BUZIK
Managing Director
MTS Health Investors
New York, NY
ELIZABETH J. CAMPBELL
Principal
SV Life Sciences Advisors, LLC
Boston, MA
JAMIL BEG
Director, Business Development
Sage Therapeutics, Inc.
Cambridge, MA
NICOLE CARKNER
Executive Director
Quad City Health Initiative
Davenport, IA
ALI BEHBAHANI, MD
Partner
NEA
Chevy Chase, MD
EDWARD CHAN
Senior Associate
NaviMed Capital
Rosslyn, VA
ERIC BELL
Senior Director
Intellectual Ventures
Seattle, WA
BRIAN G. CHOI, MD
Associate Professor of Medicine & Radiology
George Washington University
Washington, DC
EDDIE CISNEROS
Vice President, Business Development
DAVITA HEALTHCARE PARTNERS
Chicago, IL
RYAN COCHRAN
Associate
New Leaf Venture Partners
New York, NY
BRETT COHEN
Corporate Vice President
Fresenius Medical Care
Waltham, MA
CAROLYN COLACICCO
Senior Manager
TriVascular
Santa Rosa, CA
DANIEL J. CURRAN, MD
Vice President, Therapeutic Area Lead
Takeda Pharmaceutical Company
Cambridge, MA
JAY DESAI
Entrepreneur
PatientPing
Boston, MA
SALIL V. DESHPANDE, MD
UnitedHealthcare Community Plan of Texas
Houston, TX
continued on next page
29
Health Care Program Mentors
PITAMBER “PITOU” DEVGON, MD
Co-Founder
Creative Vascular, Inc.
Philadelphia, PA
CHRIS DUKE
Executive Director
International Commercial Relations
NPS Pharmaceuticals
Bedminster, NJ
CATHY K. EDDY
President
Health Plan Alliance
Irving, TX
BRANDON EINSTEIN
Associate
Goldman Sachs
New York, NY
RAMI ELGHANDOUR
Chief Business Officer
Nevro
Menlo Park, CA
MYRIAN EXUME
Director, Global Commercialization
Bristol-Myers Squibb
Princeton, NJ
DANIEL FAGA
Principal
Centerview Partners
San Francisco, CA
MING FANG
Principal
Safeguard Scientifics, Inc.
Wayne, PA
MICHAEL FAZEKAS
Vice President
Flexpoint Ford, LLC
Chicago, IL
MIHIR C. GANDHI
Director,
Healthcare Venture Investments
AVIA Innovation Accelerator
Chicago, IL
MICHAL GATTNAR
Managing Director
Pavis Capital
Mill Valley, CA
SIMEON J. GEORGE, MD
Partner
SR One Ltd
San Francisco, CA
KYLE GILBRIDE
Senior Associate
HEALTHAGEN, a subsidiary
of Aetna
New York, NY
LETICIA LAZARIDIS GOLDBERG
Investment Management
Earnest Partners - Brazil Office
Rio de Janeiro, Brazil
BRIAN P. GOLDSTEIN, MD
Executive Vice President
and Chief Operating Officer
UNC Hospitals
Chapel Hill, NC
VIKAS GOYAL
Associate
SR One
Cambridge, MA
VLAD HOGENHUIS, MD
Senior Vice President, Global Franchise
Leader CardioVascular
GlaxoSmithKline
Brentford, UK
SAM HOLLIDAY
Vice President, Corporate Development
& Strategy
Everyday Health
New York, NY
TODD HOLMES
Director
Gurnet Point Capital
Boston, MA
BRIAN HOLZER
Senior Vice President,
Diversified Businesses
Allegheny Health Network
Pittsburgh, PA
JARED HOPKINS
Director
Strategic Finance and
Business Consulting
University of Michigan
Health System
Ann Arbor, MI
NOUHAD HUSSEINI
Senior Director,
Business Development
Regeneron Pharmaceuticals
Tarrytown, NY
EMILY COOPER JANVEY
Vice President
TPG Special Situations Partners
San Francisco, CA
TODD GUREN
Product Development Manager
Providence Health Plans
Portland, OR
MAGGIE HILL JARRETT
Senior Manager, Corporate Strategy
& Business Development
McKesson
Denver, CO
PHILIP GUTRY
Principal
MPM Capital
PRASHANTH JAYARAM
Healthcare Analyst
Citadel Group
New York, NY
DOUGLAS C. FISHER, MD
Partner
InterWest Partners
Menlo Park, CA
JOHN HARRIS
Principal
DGA Partners
Bala Cynwyd, PA
PETER FISHMAN
Founder
Tolograph
New York, NY
BOSUN HAU
Partner
MVM Life Science Partners
Boston, MA
VIVEK K. JAYARAMAN
Vice President –
Global Sales & Marketing
TriVascular, Inc.
Santa Rosa, CA
AARON FLINK
Sr. Manager, Corp. Strategy
and Business Development
McKesson
San Francisco, CA
DAVID HECHT
Vice President
Formation Capital
Alpharetta, GA
EVAN S. FIELDSTON, MD
Assistant Professor of Pediatrics,
Perelman School of Medicine;
Attending Physician General Pediatrics,
Director Care Model Innovation,
The Children’s Hospital of Philadelphia
Philadelphia, PA
CHRIS FRANCK
Partner, Life Sciences & Health Care
Deloitte Consulting, LLP
Parsippany, NJ
30
SARAH FREW
Director, Business and
Commercial Development
Tetralogic Pharmaceuticals
Malvern, PA
CARRIE HIEBELER
Senior Investment Officer
Ventas, Inc.
Chicago, IL
PHIL HEIFETZ
President and CEO
EyelC, Inc.
W. Conshohocken, PA
TRACY K. JOHNSON
Vice President
Health Strategies and Solutions
Philadelphia, PA
FABIO ALEXANDRE JUNG
Director/Investment Banking Brazil
Deutsche Bank
São Paulo, Brazil
KARL M. KELLNER
Director
McKinsey & Company, Inc.
New York, NY
RON C. KERO
Vice President,
Business Development & Operations
VHA West Coast Insurance
& Financial Services
Renton, WA
RUHI KHAN
Acorda Therapeutics
Hawthorne, NY
DAVID KIBBE
Divisional Vice President, Acute Care
Universal Health Services
King of Prussia, PA
MIKE KIJEWSKI
Founder
Gamma Basics
Carlsbad, CA
JOYCE KIM
Senior Managerial Consultant
Kaiser Permanente Ventures
Oakland, CA
STEPHEN KIM
Associate
Goldman, Sachs & Co.
New York, NY
RYAN KIRKPATRICK
Partner
Colorado Impact Fund
Denver, CO
DAVE KONCIAK
Director, Strategic Analytics
Lawrenceville, NJ
ADAM M. KOPPEL, MD, PHD
Chief Strategy Officer & Senior Vice President
Biogen Idec
Boston, MA
MICHELLE LEE
Consultant
Kaiser Permanente Performance Excellence
San Francisco, CA
RICHARD LEE, MD
Assistant Professor
Weill Cornell Medical College
New York, NY
ELIZABETH LEIDERMAN, MD
Vice President
Nomura
New York, NY
LAUREN LISHER
Senior Director
RelayHealth/McKesson Corporation
Emeryville, CA
WESLEY NURSS
Associate
ISI Group
New York, NY
WENDY LIU
Vice President
HealthCare Royalty Partners
Stamford, CT
JAMES O’CONNELL
Principal
Safeguard Scientifics, Inc.
Wayne, PA
MARK A. LYLES, MD
Chief Strategic Officer
Medical University of South Carolina
Charleston, SC
JENNIFER O’NEILL
Brand Manager, Effient
Daiichi Sankyo Inc.
Parsippany, NJ
CAROLYN MAGILL
Senior Vice President,
Payer Strategy & Operations
Evolent Health
Arlington, VA
CARY PFEFFER, MD
Partner
Third Rock Ventures
Boston, MA
JEFFREY D. MARRAZZO
President and CEO
Spark Therapeutics Inc.
Philadelphia, PA
GARY M. PHILLIPS, MD
Senior Vice President and
Chief Strategy Officer
Mallinckrodt Pharmaceuticals
Hazelwood, MO
ALISON MARX
Operating Officer, Dept. of Pediatrics
The Children’s Hospital of Philadelphia
Philadelphia, PA
JOHN PICASSO
Senior Associate
Fifth Street Management LLC
White Planis, NY
GREGG MCCONNELL
Sr. Manager, Business Development
Pfizer
New York, NY
SALLY POBLETE
Founder and CEO
Wellthie Inc.
New York, NY
ROBERT C. MCDONALD, MD
President
Aledo Consulting, Inc.
Indianapolis, IN
LEN PODOLSKY
Director of Operations
Connolly, LLC
Conshohocken, PA
REGAN MURPHY
Chief of Staff / Client Manager
Valence Health
Chicago, IL
AMIKA PORWAL
Senior Associate
Booz & Company
Chicago, IL
HAREESH NAIR
Vice President
Quadria Capital Investment Mgmt. Pte Ltd
Singapore
KEVIN PYUN
Managing Director
Consonance Capital Investors
New York, NY
DAVID B. NASH, MD
Dean, Jefferson School of Population Health
Thomas Jefferson University
Philadelphia, PA
LISA RAMON
Health Systems and Services Expert
for Latin America
McKinsey & Company
Mexico City, Mexico
TY NELSON
Executive Vice President Operations
Health Carousel LLC
Cincinnati, OH
ADAM LESSLER
Engagement Manager
McKinsey & Company
Philadelphia, PA
PRASHANT NIKAM
Director, Global Commercial Leader,
Mozobil & Legacy Brands
Sanofi
Cambridge, MA
MICHAEL LI
Portfolio Manager
American Century Investments
Kansas City, MO
TATIANA NIKITINA
Chief Marketing Officer
xG Health Solutions
New York, NY
OSCAR LIN
Analyst
Axial Capital
New York, NY
PRIYA NILEKANI
Senior Managerial Consultant
Kaiser Permanente
Oakland, CA
LINDSAY RAND
Senior Manager, Strategic Initiatives Office
University of Chicago Medicine
Chicago, IL
DONNA BRADY RAZIANO, MD
Mercy Home System,
Mercy Home and Community
Health Services
Philadelphia, PA
ERIC REDLINE
Vice President Client Delivery
Pharma Metrics
Fort Washington, PA
JOSHUA RESNICK, MD
Venture Partner, Atlas Venture;
CEO, Ataxion Therapeutics
Cambridge, MA
continued on next page
31
BEN RHEE
Senior Manager – Life Sciences Strategy
Accenture
Philadelphia, PA
JAMES RHODES
Senior Consultant
Deloitte Consulting LLP
Dallas, TX
JAMES F. RICHTER
Vice President
Business Development
RedMed
Paoli, PA
AMANDA HOPKINS TIRRELL
Chief Operating Officer
Georgia Regents Medical Associates,
Medical College of Georgia
Augusta, GA
ANNE SISSEL
Vice President
Dean Bradley Osborne
San Francisco, CA
ERIC TRÉPANIER
Vice President,
Commercial Clinical Strategy & Analytics
WebMD/Medscope
New York, NY
JONTHAN SOLOMONS
President & CEO
Tabor Children’s Services
Philadelphia, PA
SAFIA K. RIZVI
Managing Director
UCB India Private Limited
Mumbai, India
MAUREEN A. SPIVACK
Managing Director
KPMG Corporate Finance LLC
New York, NY
EDMONDO J. ROBINSON, MD
Associate Chief Medical Officer,
Physician in Chief
Christiana Care Health System
Wilmington, DE
BHUVAN SRINIVASAN
Associate
KKR
Mumbai, India
PAMELA RODMAN
Administrative Director
Columbia University
New York, NY
BENJAMIN ROOKS
Managing Director
ST Advisors, Inc.
San Francisco, CA
MICHAEL ROVINSKY
Executive Director, Strategic Planning
Kaiser Permanente of the
Mid-Atlantic States
Rockville, MD
ANIL SAGGI
M&A Director
Novartis
Stockholm, Sweden
DAVID SCHUPPAN
Partner
Cressey & Company LP
Chicago, IL
SVEN SEYFFERT
Senior Business Director
Medtronic
Singapore
AMIT B. SHAH, MD
Associate Principal
McKinsey & Company
New York, NY
ANKIT SHAH
Sr. Marketing Manager
Intersect ENT
Menlo Park, CA
JONATHAN SHANNON
Executive Director
Universal American
(Collaborative Health Systems)
Atlanta, GA
SHAFINA SHEHNAZ
Vice President
Goldman Sachs & Co.
New York, NY
32
DAVID SILK
Director
Digital Acceleration, US Marketing
Pfizer
New York, NY
JAMES STANFORD
Principal
Fitzroy Health
Upper Montclair, NJ
MEIR STEIN
Director of Marketing Development
Satellite Healthcare
San Jose, CA
JÉRÔME STEVENS, MD
CEO
Patientys
(subsidiary of Direct Medcica Group)
Boulogone, France
SCOT STEVENS
Public Equity Partner
Orbi Med Advisors LLC
New York, NY
PATRICK SULLIVAN
Vice President
GMT Capital Corp.
New York, NY
RUTH SUTER
Senior Director,
Market Access and Patient Services
BioMarin Pharmaceutical Inc.
Novato, CA
VIC TANDON
Sr. Manager,
Health and IT Strategy
West Health Institute
La Jolla, CA
JARED TEO
Sr. Program Officer
California Health Care Foundation
San Francisco, CA
PAUL V. THOMAS
Business Unit Head – Biosimilars
Biocon Ltd.
Bangalore, India
PAUL TIRJAN
Vice President, Ambulatory Care
Universal Health Services, Inc.
King of Prussia, PA
JOHN URQUHART
Senior Associate
HealthCare Royalty Partners
Stamford, CT
LISA VARSHNEY
Associate Partner
Rosetta Marketing Strategy
& Insights Practice
New York, NY
DAVID WALTON
Chief Commercial Officer
AgaMatrix
Salem, NH
JASON WEIDMAN
Vice President and General Manager,
Medtronic Coronary Vascular
Medtronic
Santa Rosa, CA
CHRIS WILKERSON
President
EquipSystems, LLC
New York, NY
JOHN WINKELMAN
President
Winkelman Associates Inc.
Irvine, CA
ANDREW W. WONG
SciClone Pharmaceuticals, Inc.
Shanghai, China
DANIEL YIP
Senior Director, Global Marketing
Intercept Pharmaceuticals
New York, NY
STEPHEN E. YODER, MD
Global Lead, CV/Metabolic Search
& Evaluation, Bus. Dev.
Princeton, NJ
ELLEN S. YOON
Global Health Care Subject Matter Expert
IBM Corp.
New York, NY
KEELY ZIPP
Director Oncology Operations,
Global Oncology Franchise
GlaxoSmithKline
Collegeville, PA
THOMAS ZIPP
Global Brillinta Business Insight Lead,
Brillinta
AstraZeneca
Wilmington, DE
Administration
GEOFFREY M. GARRETT, PH.D.
Dean,
The Wharton School
HOWARD KAUFOLD, PH.D.
Vice Dean and Director,
The Wharton Graduate Division
SCOTT E. HARRINGTON, PH.D.
Chair,
Health Care Management Department, The Wharton School;
Director,
JUNE M. KINNEY, M.A.
Associate Director,
CHRISTINE ALESZCZYK
Administrative Coordinator,
JANICE SINGLETON
Administrative Coordinator,
33
Faculty
The Program Faculty are drawn from
the Wharton School, the School of
Medicine, the School of Nursing, and
the School of Arts and Sciences at the
University of Pennsylvania and leading
health institutions in Philadelphia.
Additional support is provided by the
Fellows and Associates of the Leonard
Davis Institute of Health Economics.
EUGENIO ANESSI, PH.D.
Professor, Public Management,
Bocconi University Graduate School
of Management, Milan, Italy;
Lecturer and Senior Fellow,
Health Care Management,
The Wharton School
DAVID A. ASCH, M.D., M.B.A.
Executive Director,
Penn Medicine Center for Health
Care Innovation;
Professor of Medicine,
Perelman School of Medicine
at the University of Pennsylvania;
Professor, Health Care Management,
The Wharton School
THOMAS E. BAKER, J.D.
William Maul Measey Professor of
Law and Health Sciences, University
of Pennsylvania Law School;
Professor of Health Care Management,
The Wharton School
LAWTON R. BURNS, PH.D., M.B.A.
James Joo-Jin Kim Professor of Health
Care Management, The Wharton School;
Faculty Co-Director,
Roy and Diana Vagelos Program
In Life Sciences & Management
PATRICIA M. DANZON, PH.D.
Celia Z. Moh Professor of Health Care
Management and Business Economics,
The Wharton School
GUY DAVID, PH.D.
Associate Professor,
The Wharton School
BENJAMIN DORANZ, PH.D., M.B.A.
President and CEO, Integral Molecular,
Inc.; Senior Fellow, Health Care
Management, The Wharton School
34
EZEKIEL J. EMANUEL, M.D., PH.D.
Diane v.S. Levy and Robert M.
Levy University Professor and
Vice Provost for Global Initiatives;
The Wharton School
ROBERT I. FIELD, J.D., PH.D., M.P.H.
Professor of Law at the Earle Mack School
of Law and Professor of Health Management
and Policy at the School of Public Health
at Drexel University, Philadelphia;
Lecturer, Health Care Management,
The Wharton School
BRADLEY M. FLUEGEL
Senior VP & Chief Strategy
Officer, Walgreens;
The Wharton School
THOMAS N. GILMORE, M.ARCH.
Vice President,
The Center for Applied Research Inc.;
Senior Fellow, Health Care Management,
The Wharton School
JOHN P. GLASER, PH.D.
Chief Executive Officer,
Health Systems Business Unit, Siemens;
Lecturer, Health Care Management
The Wharton School
HENRY A. GLICK, PH.D.
Perelman School of Medicine at
the University of Pennsylvania;
The Wharton School
MATTHEW R. GRENNAN, PH.D.
Assistant Professor,
The Wharton School
Chair, Health Care Management
Department, and Director,
Health Care Management Program,
The Wharton School
Alan B. Miller Professor of Health Care
Management and Business Economics
and Public Policy, The Wharton School
JOHN C. HERSHEY, PH.D.
Anheuser-Busch Professor Emeritus
of Management Science; and
The Wharton School
NAOKI IKEGAMI, M.D.
Professor, Keio University School of
Medicine, Tokyo, Japan; Senior Fellow,
The Wharton School
JOHN KIMBERLY, PH.D.
Henry Bower Professor of Entrepreneurial
Studies; Professor of Management,
Health Care Management, and Sociology,
The Wharton School
JUNE M. KINNEY, M.A.
Associate Director, Graduate Program
in Health Care Management;
The Wharton School
JONATHAN T. KOLSTAD, PH.D.
Assistant Professor, Health Care
GARY J. KURTZMAN, M.D.
Vice President, Life Sciences,
Safeguard Scientifics; Lecturer,
The Wharton School
JEFFREY P. LIBSON, J.D.
Partner, Pepper Hamilton LLP;
The Wharton School
HARI MAHADEVAN, PH.D.
Independent Consultant;
The Wharton School
DANIEL N. MENDELSON. M.P.P.
CEO and Chairman, Avalere Health Inc.;
Lecturer, Health Care Management;
The Wharton School
STEVEN A. NICHTBERGER, M.D.
Adjunct Professor and Senior Fellow,
The Wharton School
MITESH S. PATEL, M.D.
Assistant Professor of Medicine, Perelman
School of Medicine at the University
of Pennsylvania School of Medicine;
Assistant Professor of Health Care
MARK V. PAULY, PH.D.
John M. and Thomas L. Bendheim
Professor; Professor, Health Care
Management, Business Economics and
Public Policy, The Wharton School;
Professor, Economics, College of Arts
and Sciences
WILLIAM P. PIERSKALLA, PH.D.
Professor Emeritus
DANIEL POLSKY, PH.D.
Robert D. Eilers Professor of Health Care
Management and Economics,
The Wharton School;
Executive Director, Leonard Davis
Institute of Health Economics
DOUGLAS A. PRESENT, M.B.A.
Independent Consultant;
The Wharton School
ARNOLD J. ROSOFF, J.D.
Professor Emeritus,
Legal Studies and Business Ethics;
The Wharton School
STEPHEN M. SAMMUT
Lecturer, Entrepreneurial Programs,
The Wharton School
CYNTHIA SCALZI, M.N., PH.D.
Professor Emeritus of Nursing
and Health Care Management,
The Wharton School
RACHEL M. WERNER, M.D., PH.D
Associate Professor of Medicine,
University of Pennsylvania School of
Medicine; Associate Professor and Senior
Fellow, Operations and Information
Management, Health Care Management,
The Wharton School
JOHN J. WHITMAN, M.B.A.
Executive Director, The TRECS Institute;
The Wharton School
SANKEY V. WILLIAMS, M.D.
Sol Katz Professor of General
Internal Medicine; Professor,
The Wharton School
J. SANFORD SCHWARTZ, M.D.
Leon Hess Professor in Internal
Medicine, Perelman School of Medicine
The Wharton School
JEFFREY H. SILBER, M.D., PH.D.
Director, Center for Outcomes Research,
The Children’s Hospital of Philadelphia;
Professor of Pediatrics and
Anesthesiology & Critical Care,
Perelman School of Medicine at
the University of Pennsylvania;
The Wharton School
JEFFREY A. SOLOMON, M.D., M.B.A.
Founding Partner, Infiniti Medical LLC;
The Wharton School
JUNE KINNEY
Associate Director, MBA Program
in Health Care Management
The Wharton School
AMANDA STARC, PH.D.
The Wharton School
ASHLEY SWANSON, PH.D.
The Wharton School
Questions or complaints regarding
this policy should be directed to:
Executive Director,
Office of Affirmative Action
and Equal Opportunity Programs
Sansom Place East
3600 Chestnut Street, Suite 228
215.898.6993 (Voice)
215.898.7803 (TDD)
ROBERT J. TOWN, PH.D.
Associate Professor,
The Wharton School
KEVIN G.M. VOLPP, M.D., PH.D.
Director, Center for Health Incentives
and Behavioral Economics,
Leonard Davis Institute;
The Wharton School
The University of Pennsylvania
values diversity and seeks talented
students, faculty and staff from diverse
backgrounds. The University of
Pennsylvania does not discriminate
on the basis of race, sex, sexual
orientation, gender identity, religion,
color, national or ethnic origin, age,
disability, or status as a Vietnam Era
Veteran or disabled veteran in the
administration of educational policies,
programs or activities; admissions
policies; scholarship and loan awards;
athletic, or other University administered programs or employment.
Director,
MBA Program in
The Wharton School
©2004, The Trustees of
the University of Pennsylvania.
All rights reserved.
Photography of Students: Stuart Watson
Book Design: www.HollisterCreative.com
35
Wharton
The Wharton School
University of Pennsylvania
3641 Locust Walk
215.898.6861
fax 215.573.2157

resume - Health Care Management Department

Transcription

Similar documents

about take command health

InBody720 Spec Sheet

jd/mba program - University of Pennsylvania Law School

Cavalia inc. 5100, rue Hutchison, suite 300 Montréal (Québec) H2V

March 21, 2005 - Dolphin Student Group Web Accounts

smart healthcare consumer

Early Childhood Inte..

Do you have joint pain? It could be Rheumatoid Arthritis.

CapnalOne" healthcare finance"

PDR-13-30-10:Layout 1.qxd - Philadelphia Public Record

current issue